Original Article
Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension
N Engl J Med 2003; 348:2407-2415June 12, 2003
- Abstract
Background
It is uncertain whether ambulatory blood-pressure measurements recorded for 24 hours in patients with treated hypertension predict cardiovascular events independently of blood-pressure measurements obtained in the physician's office and other cardiovascular risk factors.
Methods
We assessed the association between base-line ambulatory blood pressures in treated patients and subsequent cardiovascular events among 1963 patients with a median follow-up of 5 years (range, 1 to 66 months).
Results
We documented new cardiovascular events in 157 patients. In a Cox proportional-hazards model with adjustment for age, sex, smoking status, presence or absence of diabetes mellitus, serum cholesterol concentration, body-mass index, use or nonuse of lipid-lowering drugs, and presence or absence of a history of cardiovascular events, as well as blood pressure measured at the physician's office, higher mean values for 24-hour ambulatory systolic and diastolic blood pressure were independent risk factors for new cardiovascular events. The adjusted relative risk of cardiovascular events associated with a 1-SD increment in blood pressure was 1.34 (95 percent confidence interval, 1.11 to 1.62) for 24-hour ambulatory systolic blood pressure, 1.30 (95 percent confidence interval, 1.08 to 1.58) for ambulatory systolic blood pressure during the daytime, and 1.27 (95 percent confidence interval, 1.07 to 1.57) for ambulatory systolic blood pressure during the nighttime. For ambulatory diastolic blood pressure, the corresponding relative risks of cardiovascular events associated with a 1-SD increment were 1.21 (95 percent confidence interval, 1.01 to 1.46), 1.24 (95 percent confidence interval, 1.03 to 1.49), and 1.18 (95 percent confidence interval, 0.98 to 1.40).
Conclusions
In patients with treated hypertension, a higher ambulatory systolic or diastolic blood pressure predicts cardiovascular events even after adjustment for classic risk factors including office measurements of blood pressure.
Media in This Article
Figure 1
Hourly Means of Systolic and Diastolic Blood Pressure Derived from 24-Hour Ambulatory Blood-Pressure Recordings Obtained at Base Line (Visit 3) in the 1963 Participants.Figure 2
Incidence of Cardiovascular Events According to Category of Office Systolic Blood Pressure.Article Activity
- Article
Several prospective clinical studies, as well as population-based studies, have indicated that the incidence of cardiovascular events is predicted by blood pressure as measured conventionally or with ambulatory methods, even after adjustment for a number of established risk factors.1-11 In some of these studies, ambulatory measurements of blood pressure predicted cardiovascular events even after adjustment for conventional blood-pressure measurements.1,3,5,7,9,12 However, in most of these studies, the majority of data on ambulatory blood pressure, which were used to predict end points, were recorded in initially untreated subjects or during a placebo run-in phase; in most cases, treatment was initiated afterward. There is a lack of data on the prognostic value of ambulatory blood-pressure monitoring in patients with treated hypertension in whom both ambulatory measurements of blood pressure and office-based measurements of blood pressure are recorded when patients are receiving active treatment — a scenario that more closely reflects daily clinical practice for many patients. An indication that ambulatory blood-pressure measurements during treatment are superior to office blood-pressure measurements in predicting cardiovascular risk came from a recent post hoc subanalysis involving 790 patients with treated hypertension.13
We conducted the prospective, multicenter Office versus Ambulatory Blood Pressure (OvA) study to address whether ambulatory blood pressure monitored in patients with treated hypertension could predict cardiovascular events and death even after adjustment for conventional office blood-pressure measurements. To this end, 1963 patients were prospectively enrolled and followed for approximately five years.
Methods
Study Design
The study protocol was approved by the institutional review boards of the Ghent University Hospital (Ghent, Belgium) and other participating centers. All patients gave written informed consent. All decisions concerning the study design, the collection, analysis, and interpretation of the data, and the intellectual content of the manuscript were made independently by the study committees, without the involvement of the pharmaceutical-industry sponsors.
The prerequisite for inclusion was documented hypertension at two separate visits within a two-year period before enrollment (visits 1 and 2). Hypertension was diagnosed if the mean of three sphygmomanometric readings of diastolic blood pressure (assessed as the fifth Korotkoff sound and obtained in the office, when the patient was sitting, after five minutes of rest) exceeded 90 mm Hg in a patient who was currently taking antihypertensive medication or 95 mm Hg in a patient who was not taking such medication. In order to be eligible, patients had to have been treated with antihypertensive drugs for at least three months by the time of the inclusion visit (visit 3). Patients of either sex who were 18 years of age or older were eligible. Criteria for exclusion included suspicion of secondary hypertension, insulin-treated diabetes mellitus, recent stroke (occurring within the previous three months), recent acute myocardial infarction, recent hospitalization for chronic heart failure, recent revascularization or planned cardiovascular intervention during the succeeding three months, a serum creatinine concentration of more than 2.5 mg per deciliter (220 μmol per liter), chronic obstructive pulmonary disease, any coexisting diseases that might seriously reduce life expectancy, heart transplantation, use of experimental drugs, pregnancy, and refusal to undergo repeated follow-up visits and ambulatory blood-pressure monitoring. The choice of antihypertensive drugs was at the discretion of the physician, and physicians were repeatedly advised to follow current guidelines and to target a blood pressure of 140/90 mm Hg, as measured in the office while the patient was sitting.
Data Collection
At visit 3, demographic data were recorded, as well as information about traditional cardiovascular risk factors, history of cardiovascular events, and current medications (antiplatelet, antidiabetic, lipid-lowering, and other cardiovascular drugs). Anthropometric data were collected, and a routine 12-lead electrocardiogram was obtained. At that time, a sample of venous blood was drawn to assess base-line factors. Immediately after visit 3, ambulatory blood pressure was recorded over a 24-hour period during the patient's normal daily activities, with the use of properly validated and calibrated monitors programmed to obtain readings at intervals of not more than 30 minutes between 8 a.m. and 8 p.m. and at intervals of not more than 60 minutes between 8 p.m. and 8 a.m. Raw data were sent to the coordinating center and were visually inspected by a technician before being entered into the central data base. No specific editing criteria were applied to the blood-pressure readings. We planned to follow patients for up to 5.5 years.
End Points
The end-point committee identified all major end points by reviewing the patients' files and source documents or by requesting more detailed written information from the investigators; the committee was blinded with respect to all blood-pressure data. Cardiovascular events were validated according to the principles used in the Systolic Hypertension in Europe trial.14 Stroke was defined as a neurologic deficit with symptoms continuing for more than 24 hours or leading to death with no apparent cause other than a vascular cause. Acute myocardial infarction was defined by the presence of two of the following: typical chest pain, electrocardiographic changes, and increased cardiac-enzyme concentrations. The definition of myocardial infarction did not include silent myocardial infarction. The definition of congestive heart failure required the presence of symptoms, clinical signs, and a need for treatment. Sudden death was defined as any death of unknown cause occurring immediately or within 24 hours after the onset of acute symptoms or any unwitnessed death for which no likely cause could be established on the basis of the medical history. Angina pectoris was diagnosed if there was chest pain and documented electrocardiographic signs of coronary ischemia or if there was a need for coronary revascularization in the absence of acute myocardial infarction. Patients recorded as having peripheral (noncoronary) vascular disease included those who underwent surgical or angioplastic procedures on the aorta or the arteries of the legs. Transient ischemic attacks were excluded from the statistical analysis.
Statistical Analysis
Statistical analyses were planned for the primary end point of fatal or nonfatal cardiovascular events and the secondary end points of fatal or nonfatal acute myocardial infarction or stroke, death from any cause, and death from cardiovascular causes. The study variables compared were the office blood pressure (the mean of the sphygmomanometric blood pressure readings at visit 3, obtained as described above) and the means of the 24-hour, daytime, and nighttime ambulatory measurements of systolic and diastolic blood pressure (also recorded at visit 3). Daytime ambulatory blood pressure was defined as that between 8 a.m. and 8 p.m., and nighttime ambulatory blood pressure as that between midnight and 6 a.m.15-18 We initially screened 2232 patients, but because of protocol violations (in 10 patients), technical failure (in 41 patients with poor-quality ambulatory blood-pressure recordings and 6 patients with an insufficient number of readings to allow statistical analysis), or inadequate clinical follow-up (in 212 patients), a total of 269 patients had to be excluded from final analyses, yielding 1963 eligible patients (88 percent). In all 1963 patients, office measurements of blood pressure, ambulatory measurements of blood pressure, and adequate follow-up documentation were available.
The distributions of base-line characteristics in the group of patients with cardiovascular events and the group without cardiovascular events were compared with the use of Fisher's exact test for proportions and the t-test or the Mann–Whitney U test for continuous variables. Cox proportional-hazards models were used to estimate relative risks (with 95 percent confidence intervals) for events associated with a 1-SD increment in blood pressure, with adjustment for sex, age, body-mass index (the weight in kilograms divided by the square of the height in meters), smoking status, presence or absence of diabetes mellitus, serum cholesterol concentration, use or nonuse of lipid-lowering drugs, and history of cardiovascular events. All statistical analyses were performed with the use of SAS software, version 6.12 (SAS Institute).
Results
Characteristics of the Patients
The median duration of follow-up was 5 years (range, 1 to 66 months). The event committee validated first cardiovascular events during follow-up in 157 patients (combined incidence of fatal and nonfatal cardiovascular events, 12.8 per 1000 person-years). Fatal events occurred in 78 patients (incidence, 6.1 deaths per 1000 person-years), and 38 of these events were cardiovascular events. Patients who had cardiovascular events were older than those who did not have such events (P<0.001), were more likely to be male (P<0.001), and had a higher prevalence of diabetes mellitus (P<0.001) and previous cardiovascular disease (P<0.001). In addition, they had higher cholesterol levels (P=0.001) and a higher rate of use of lipid-lowering drugs (P<0.001). Characteristics of the patients according to category of ambulatory systolic blood pressure (<135 mm Hg or ≥135 mm Hg) are summarized in Table 1Table 1
Characteristics of the Patients According to Category of Ambulatory Blood Pressure.. The higher category of ambulatory blood pressure was associated with older age, male sex, current smoking, presence of diabetes mellitus, and higher office blood pressures. Fatal and nonfatal cardiovascular events and death from any cause were also more frequent among patients with an ambulatory systolic blood pressure of 135 mm Hg or higher.Office and Ambulatory Blood Pressures as Predictors of Risk
Cox proportional-hazards analysis for each outcome variable was performed with the use of fixed clock-time definitions of both daytime and nighttime ambulatory blood pressure. Table 2Table 2
Relative Risks Associated with Office and Ambulatory Measurements of Systolic and Diastolic Blood Pressure at Entry. shows the relative risks (and 95 percent confidence intervals) associated with a 1-SD increment in blood pressure after adjustment for sex, age, body-mass index, smoking status, presence or absence of diabetes mellitus, serum cholesterol concentration, use or nonuse of lipid-lowering drugs, and presence or absence of a history of cardiovascular events. Both office and ambulatory measurements of systolic and diastolic blood pressure significantly predicted the primary end point of fatal or nonfatal cardiovascular events. Table 3Table 3
Relative Risks Associated with Ambulatory Blood-Pressure Measurements after Additional Adjustment for Office Blood Pressure at Entry. summarizes the relative risks associated with each 1-SD increment in ambulatory measurements of systolic and diastolic blood pressure after additional adjustment for office blood pressure. For the primary end point, 24-hour and daytime ambulatory systolic and diastolic blood pressure predicted outcome even after adjustment for office blood pressure. The mean 24-hour blood-pressure measurements at base line for patients who had a cardiovascular event and those who did not are shown in Figure 1Figure 1Hourly Means of Systolic and Diastolic Blood Pressure Derived from 24-Hour Ambulatory Blood-Pressure Recordings Obtained at Base Line (Visit 3) in the 1963 Participants.. Results were similar for the end point of fatal or nonfatal myocardial infarction or stroke (Table 3).We also examined separately the cerebrovascular and coronary outcomes (although this was not a prespecified aim, and the numbers were small). Systolic blood pressure as measured in the office independently predicted the risk of cerebrovascular events (36 patients had such an event; relative risk associated with a 1-SD increment in office systolic blood pressure, 1.50 [95 percent confidence interval, 1.08 to 2.08]), and ambulatory blood pressure was not predictive of the risk of cerebrovascular events after adjustment for office blood pressure. However, 24-hour and daytime ambulatory systolic blood pressure predicted the risk of coronary events (which occurred in 42 patients) even after adjustment for office blood pressure (relative risk associated with a 1-SD increment in ambulatory systolic blood pressure, 1.63 [95 percent confidence interval, 1.10 to 2.42] and 1.68 [95 percent confidence interval, 1.14 to 2.48], respectively). None of the ambulatory blood-pressure variables predicted the risk of death from any cause (Table 2 and Table 3) or death from cardiovascular causes (which occurred in 38 patients; data not shown).
As compared with patients with a mean 24-hour systolic blood pressure of less than 135 mm Hg, patients with a 24-hour ambulatory systolic blood pressure of 135 mm Hg or higher had a relative risk of cardiovascular events, with adjustment for office blood pressure and other potential confounders, of 1.74 (95 percent confidence interval, 1.15 to 2.63). Figure 2Figure 2
Incidence of Cardiovascular Events According to Category of Office Systolic Blood Pressure. further illustrates the higher incidence of cardiovascular events with higher ambulatory blood-pressure measurements among patients in each of three categories of office systolic blood pressure (<140 mm Hg, 140 to 159 mm Hg, and ≥160 mm Hg).A higher pulse pressure (calculated as the systolic pressure minus the diastolic pressure) was also predictive of cardiovascular events (data not shown). However, neither office nor ambulatory measurements of pulse pressure independently predicted the risk of cardiovascular events according to a model including the ambulatory systolic or diastolic blood pressure. Neither the ratio of nighttime systolic blood pressure to daytime systolic blood pressure nor the ratio of nighttime diastolic blood pressure to daytime diastolic blood pressure was an independent predictor of the risk of cardiovascular events (data not shown).
Discussion
The results of our large-scale prospective study demonstrate that, after adjustment for classic risk factors including office blood pressure, the 24-hour ambulatory blood pressure provided additional prognostic information concerning cardiovascular events, including a combined outcome of nonfatal or fatal myocardial infarction or stroke. However, this measure did not predict the risk of death from any cause.
The findings of our study, in which all ambulatory measurements of blood pressure were obtained in treated patients, are consistent with those of previously published outcome studies,1-11 in which ambulatory blood-pressure measurements were obtained in untreated or placebo-treated subjects at the time of inclusion in the study.
In the substudy of the Systolic Hypertension in Europe trial addressing ambulatory blood pressure,9 about 800 patients underwent ambulatory blood-pressure monitoring during the placebo run-in period before undergoing randomization to placebo or active treatment. In the placebo group, ambulatory systolic blood pressure predicted cardiovascular complications after cumulative adjustments for age, sex, smoking status, presence or absence of previous cardiovascular complications, residence or nonresidence in western Europe, and conventional blood-pressure measurements. The participants in that study were elderly patients with isolated systolic hypertension, and in contrast to our study, that study showed that ambulatory blood pressure did not predict the outcome in the active-treatment group.
Earlier data based on semiautomatic ambulatory blood-pressure monitoring demonstrated the potential value of ambulatory blood pressure in discriminating between hypertensive patients at high cardiovascular risk and those at lower risk; these data showed that such discrimination was possible on the basis of the variance in the daytime ambulatory blood pressure, which was not explained by readings obtained in the clinic.1,12 In that study, for technical reasons, no nighttime monitoring was performed, which resulted in incomplete documentation of the 24-hour profile.
Among referred patients with hypertension included in the Progetto Ipertensione Umbria Monitoraggio Ambulatoriale prospective registry, the base-line ambulatory blood pressure measured before treatment began was an independent predictor of the risk of cardiovascular events.8,19,20 In that study, the authors focused on the increased risk associated with a blunted nocturnal decrease in blood pressure but did not directly compare office blood pressure measured in treated patients with ambulatory blood pressure. A post hoc subgroup analysis suggested an association between the ambulatory blood pressure in patients whose blood pressure was adequately controlled by treatment and a reduced risk of cardiovascular events that was independent of other traditional risk factors.13 Office blood-pressure values in treated patients were not significantly related to cardiovascular risk. However, the design of that study differed substantially from our protocol. The authors recorded 24-hour blood pressure with ambulatory monitoring in treated patients an average of 3.7 years after their enrollment in the registry and did not study fatal events.
In a large sample of a Japanese community comprising both treated and untreated subjects, ambulatory blood pressure also predicted the risk of fatal cardiovascular events, even after adjustment for age, sex, risk factors, medication, cardiovascular history, and conventional blood pressure.3,21,22 In a study of 688 patients with hypertension followed for more than nine years, the ambulatory intraarterial blood pressure recorded before treatment began was predictive of cardiovascular risk. In our study, a noninvasive approach to ambulatory monitoring of blood pressure was used.
The prognostic value of ambulatory blood pressure has also been assessed in a small study of patients with treatment-refractory hypertension.5 Higher values for ambulatory blood pressure more accurately predicted future cardiovascular events than did clinic-based measurements of blood pressure. The mean blood pressure among patients in that study was considerably higher than the mean pressure in our study. In general, the patients we studied could not be considered to have true refractory hypertension, although it is possible that a small proportion of our patients presented with drug-resistant hypertension.
Some limitations of our study should be noted. We did not have the necessary information to adjust adequately for a family history of coronary artery disease, urinary albumin excretion, levels of low-density lipoprotein cholesterol or high-density lipoprotein cholesterol, levels of physical activity, or dietary measures. Thus, we could not account for the effect of these variables on cardiovascular outcomes.
The results of our study clearly demonstrate the limitations of office readings as they are routinely obtained. In our study, three blood-pressure readings from a single office visit were averaged for use as a measure of office blood pressure. By contrast, in the Systolic Hypertension in Europe study, conventional blood pressure was calculated on the basis of six readings (two readings from each of three visits).9,14 Fagard et al.23 demonstrated that the correlations between left ventricular mass and clinic blood pressure and between left ventricular mass and ambulatory blood pressure became much closer when clinic readings were better standardized and when the readings were averaged over more than one visit. That study suggests that for direct comparisons between conventional and ambulatory measurements of blood pressure, it is best to use repeated, standardized conventional readings obtained at prespecified intervals. The use of protocols that are not well standardized in the assessment of the office blood pressure may lead to a high degree of variance in this measure, particularly among treated patients such as those in our study.
Another weakness of routine blood-pressure measurement that may have influenced our results is that the effects of drugs (e.g., peak and trough effects) may have had a greater influence on the variance in office readings than on that in 24-hour ambulatory readings. Our study was not designed to address the effects of individual drugs or classes of drugs; therefore, patients were allowed to take all classes of drugs, which were administered at the discretion of their physicians.
Patients enrolled in our study were not optimally treated, as judged by their office readings at visit 3 (only 25 percent had an office systolic blood pressure below 140 mm Hg). Yearly follow-up visits failed to show improvement (data not shown), although participating physicians were continuously asked to adhere more closely to the target office blood pressure of 140/90 mm Hg. It is well recognized24,25 that in follow-up visits in observational studies, the proportion of patients with adequately controlled blood pressure is still far from optimal. In this sense, our study is a more accurate reflection of everyday practice than are studies in which blood pressure is better controlled.
Our study shows that 24-hour ambulatory blood pressure predicts the risk of cardiovascular events even after adjustment for classic risk factors including office blood pressure. The next step will be to determine the role of ambulatory blood-pressure monitoring in clinical practice and whether the cost–benefit ratio favors adding such monitoring to the standard care of patients with treated hypertension.26,27
Supported by the Flemish Science Foundation (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen), the University of Ghent, the University Hospital of Ghent, AstraZeneca, Boehringer Ingelheim, Roche, Pfizer, Servier-Eutherapie Benelux, the Rotary Club Ghent, and the Stichting Gezondheidszorg Nollet.
We are indebted to Mrs. Linda Packet for her help in administering the study and her help in the preparation of the manuscript, and to Mrs. Gerda Bollaert and Mrs. Marleen Van Hecke for their logistic help during the study.
Source Information
From the Departments of Cardiovascular Diseases (D.L.C., M.L.D.B., D.A.D., P.J.G.) and Public Health (D.A.D.B.), Ghent University, Ghent, Belgium; the Department of Medicine, University Hospital Maastricht, Maastricht, the Netherlands (P.W.L.); the Cardiovascular Division, University of Minnesota, Minneapolis (D.A.D.); the Hypertension and Cardiovascular Rehabilitation Unit, University of Leuven, Leuven, Belgium (R.H.F.); the Department of Cardiology, Algemeen Ziekenhuis St. Jan, Bruges, Belgium (L.H.M.); the Department of Internal Medicine, Vlietland Hospital, Schiedam, the Netherlands (J.J.B.); the Department of Internal Medicine and Hypertension, Vrije Universiteit Brussel, Brussels, Belgium (R.O.S., P.V.D.N.); and the Blood Pressure Unit and Arterial Disease, Assessment, Prevention, and Treatment Centre, Beaumont Hospital, Dublin, Ireland (E.O.).
Address reprint requests to Dr. Clement at the Department of Cardiology and Angiology, University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium, or at denis.clement@skynet.be.
The Office versus Ambulatory Blood Pressure (OvA) Study Investigators are listed in the Appendix.
Appendix
The Office versus Ambulatory Blood Pressure (OvA) study was conducted under the auspices of the European Society of Hypertension, the European Society of Cardiology, and the Belgian Hypertension Committee. The following investigators were responsible for the coordination of the participating clinicians (an asterisk denotes deceased): Trial coordinator — D. Clement; National coordinators — L. Caparovski* (Republic of Macedonia), M. Carrageta (Portugal), R. Cifkova (Czech Republic), J.P. Degaute (Belgium), P. de Leeuw (the Netherlands), M. Lapinski (Poland), J.M. Mallion (France), E. O'Brien (Ireland), P. Palatini (Italy), J.L. Rodicio (Spain); Coordinators of Belgian general practices — J. Beys, K. Bruyneel, M. Bury, D. De Clercq, D. Defrance, J. Deheneffe, Y. Deheneffe, P. De Jaegher, A. Friart, L. Geutjens, M. Gysbrechts, A. Herman, M. Kahan, A. Kassab, L. Labaki, P. Lafontaine, J. Lalmand, H. Lesseliers, D. Mertens, E. Mievis, E. Robbens, R. Six, C. Stevens, Y. Streulens, J. Thoeng, P. Timmermans, P. Van Der Niepen, A. Van Dorpe, E. Van Houwe, P. Van Iseghem, P. Vermeersch; Protocol Committee — D.L. Clement, A. Coats, J. Conway,* G. Mancia, E. O'Brien; End-Point Committee — P. de Leeuw, R. Fagard (chairs), D. Duprez and P. Gheeraert (associate members); Publication Committee — D.L. Clement, M. De Buyzere, P. de Leeuw, R. Fagard, E. O'Brien; Data Monitoring Committee — D. De Bacquer (statistical analysis), M. De Buyzere, L. Missault, L. Packet; Ethics Committee — W. Birkenhäger, M. Bogaert, A. Zanchetti.
In addition, the following investigators participated in the study: University Hospital Leuven, Campus Gasthuisberg, Leuven, Belgium — R. Fagard, J. Staessen; St. Jozefziekenhuis, Turnhout, Belgium — I. Bekaert; Centre Hospitalier Universitaire Tivoli, La Louviere, Belgium — P. Dupont; University Hospital, Ghent, Belgium — D. Duprez; Universitaire Instelling Antwerpen, Antwerp, Belgium — J. Denekens, F. Rademakers; Algemeen Ziekenhuis Stuivenberg, Antwerp, Belgium — R. Lins; Hôpital Saint Luc, Brussels, Belgium — J.F. De Plaen; Private cardiologists and general practitioners, Belgium — H. Antonneau, L. Arcache, D. Barina, S. Bartholomeeusen, M. Barvais, I. Bayon, A. Bellucci, L. Berghmans, A. Berghs, A. Bernard, K. Bertels, G. Binet, L. Bleyen, J. Bogaert, F. Bolly, L. Bonami, D. Bonhomme, M. Bonhomme, A. Boogaerts, H. Boufessile, J. Boxus, B. Brichard, L. Bril, M. Brinker, C. Busellato, J. Busschaert, J. Cambier, P. Capiau, A. Carlier, J. Caudelier, P. Cayman, H. Cerfontaine, P. Ceurvelts, P. Chapelle, G. Charlier, G. Clerinx, E. Cloot-Snyders, S. Coene, A. Collin, D. Content, M. Content, M. Coopmans, P. Cornelis, J.M. Crespeigne, M.J. Cuvelier, G. De Bilderling, R. De Bruyn, J.P. De Corte, W. De Geyseleer, F. De Greef, F. De Greve, R. De Jongh, M. De Kimpe, A. De Leeuw, L. De Lille, B. De Man, D. De Munck, J. De Pourcq, H. De Ridder, M. De Roeck, M. De Ruyttere, H. De Schryver, A. De Vlieger, L. De Voecht, J. De Vos, J. Dewachter, H. De Wit, P. De Witte, A. Decerf, J. Declerck, E. Deconinck, I. Deeren, F. Dejaegher, A. Delhauteur, D. Delsate, R. Demets, J. Dens, M. Derycke, M. Deschamps, P. Descheemaeker, G. D'Hanis, P. D'Hanis, M. D'Hollander, W. D'Hooge, P. Dieleman, R. Diels, D. Di Mattia, G. Economou, A. Elouehabi, M. Elsen, E. Ercken, F. Evrard, P. Fabry, L. Fellah, L. Ferrant, A.C. Feye, D. Flahou, R. Follet, I. Geenen, R. Gevaert, L. Gielen, L. Gillemon, F. Goethals, K. Goethals, J.C. Goffin, V. Goossens, D. Grand, G. Gras, A. Grimee, J. Grosjean, R. Haardt, I. Haumont, J. Hellebaut, K. Hendrickx, W. Hendrickx, W. Hens, C. Ho Van, M. Hubert, L. Ieven, A. Jadin, P. Jaspers, M. Joly, A. Jorion, B. Jortay, P. Joskin, G. Jouret, P. Kerckhoven, L. Kestens, E. Keutgen, G. Lambrechts, H. Lammers, P. Laskar, A. Lecocq, C. Ledoux, J. Ledune, P. Leemans, A. Lefebvre, C. Lefebvre, P. Lenaerts, D. Lesage, R. Lietaer, L. Louette, J. Luyts, R. Maes, M. Maex, S. Manceaux-Thirion, G. Marco, J. Marquet-Lochegnies, R. Martens, J. Masureel, F. Maudens, P. Maudens, J.P. Meurant, E. Meys, A. Migeotte, A. Mignot, M. Minnart, J. Moerman, J.P. Monette, A. Monoyer, A. Moonen, Y. Moons, A. Moreels, J.F. Mouvet, N. Neiman, J. Neven, F. Nollomont, J. Nuyten, W. Onsea, M. Pareit, E. Peeters, G. Peeters, L. Peremans, J.L. Perilleux, L. Phang, D. Plessers, M. Poot, D. Quertinier, J.P. Ralet, M. Rase, J.C. Reichling, R. Remmen, P. Robert, J.P. Rochet, F. Roelandts, M. Roland, J.Y. Rousseau, M. Saey, F. Sas, D. Scheveneels, L. Schillemans, E. Schreurs, B. Seront, J. Sette, M. Simons, P. Simons, P. Sisani, J. Smekens, J.F. Soupart, J.F. Spiertz, A. Spilsteyns, F. Spirlet, J. Sprenghers, J. Staelens, D. Strens, H. Stuer, C. Swinne, D. Taes, M. Talloen, M. Temmerman, P. Thibaut, D. Thiry, H.T. Tran, T. Tran Duy, Y. Urbain, P. Van Berkel, L. Van Boxelaer, J. Van Brabant, B. Van Damme, I. Van De Velde, A. Van De Weyer, F. Van Den Broek, G. Van Den Bussche, L. Van Den Eeckhout, W. Van Den Eede, B. Van den Eynden, H. Van Der Veken, W. Van Dievel, W. Van Doninck, S. Van Enis, L. Van Eupen, C. Van Haren, L. Van Heyste, L. Van Hoecke, G. Vankerckhoven, F. Van Lint, J. Van Lint,* J. Van Maele, E. Van Maerken, A.J. Van Oostveldt, C. Van Parijs, W. Van Peer, P. Van Royen, P. Van Severen, D. Van Troyen, P. Van Vlaenderen, L. Vanneste, G. Vereecken, A. Verheyen, V. Verstreken, J.P. Vervaeke, M. Vervaeke, M. Vrijdag, R. Vroonen, L. Vuylsteke, M. Vydt, C. Weber, A. Wery, S. Weyens, J. Willaert, L. Willaert, J.J. Zeiger; Institute for Clinical and Experimental Medicine, Prague, Czech Republic — R. Cifkova; Centre Hospitalier Universitaire, Grenoble, France — S. Boutelant, J.M. Mallion; Hôpital Universitaire La Miletrie, Poitiers, France — D. Herpin; Charitable Infirmary, Dublin, Ireland — E. Breslin, C. Gavin, E. O'Brien; Ospedale San Giovanni Di Dio, Florence, Italy — R. Laureano; Clinica Medica, Pavia, Italy — E. Marchesi; Ospedale Civile, San Daniele, Italy — L. Mos; Universita degli Studi di Palermo, Palermo, Italy — S. Novo; Clinica Medica, Padua, Italy — P. Palatini; General Hospital Silvestrini, Perugia, Italy — C. Porcellati, P. Verdecchia; Academy of Medicine, Warsaw, Poland — M. Lapinski, J. Lewandowski; Hospital Universitade de Coimbra, Coimbra, Portugal — G. Pego; Instituto de Cardiologia Preventiva, Almada, Portugal — M. Carrageta; Hospital de la Santa Creu, Sant Pau, Barcelona, Spain — A. Roca Cusachs; Hospital 12 Octubre, Madrid — J.L. Rodicio; University Hospital, Skopje, Republic of Macedonia — L. Caparovski,* N. Gjorgov; Vlietland Ziekenhuis, Schiedam, the Netherlands — J.J. Braun; Ikaziaziekenhuis, Rotterdam, the Netherlands — A. Dees; and Academisch Ziekenhuis Maastricht, Maastricht, the Netherlands — P. de Leeuw.
- References
References
1
Perloff D ,Sokolow M ,Cowan R . The prognostic value of ambulatory blood pressure. JAMA 1983;249:2792-2798
CrossRef | Web of Science | Medline2
Zweiker R ,Eber B ,Schumacher M ,Toplak H ,Klein W . “Non-dipping“ related to cardiovascular events in essential hypertensive patients. Acta Med Austriaca 1994;21:86-89
Medline3
Ohkubo T ,Imai Y ,Tsuji I , et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens 1997;15:357-364
CrossRef | Web of Science | Medline4
Nakano S ,Fukuda M ,Hotta F , et al. Reversed circadian blood pressure rhythm is associated with occurrence of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 1998;47:1501-1506
CrossRef | Web of Science | Medline5
Redon J ,Campos C ,Narciso ML ,Rodicio JL ,Pascual JM ,Ruilope LM . Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998;31:712-718
Web of Science | Medline6
Yamamoto Y ,Akiguchi I ,Oiwa K ,Hayashi M ,Kimura J . Adverse effect of nighttime blood pressure on the outcome of lacunar infarct patients. Stroke 1998;29:570-576
CrossRef | Web of Science | Medline7
Khattar RS ,Swales JD ,Banfield A ,Dore C ,Senior R ,Lahiri A . Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation 1999;100:1071-1076[Erratum, Circulation 1999;100:1760.]
Web of Science | Medline8
Verdecchia P ,Schillaci G ,Borgioni C ,Ciucci A ,Pede S ,Porcellati C . Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998;32:983-988
Web of Science | Medline9
Staessen JA ,Thijs L ,Fagard R , et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999;282:539-546
CrossRef | Web of Science | Medline10
Sander D ,Kukla C ,Klingelhofer J ,Winbeck K ,Conrad B . Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000;102:1536-1541
Web of Science | Medline11
Kario K ,Pickering TG ,Matsuo T ,Hoshide S ,Schwartz JE ,Shimada K . Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001;38:852-857
CrossRef | Web of Science | Medline12
Perloff D ,Sokolow M ,Cowan RM ,Juster RP . Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens Suppl 1989;7:S3-S10
CrossRef | Medline13
Verdecchia P ,Reboldi G ,Porcellati C , et al. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol 2002;39:878-885
CrossRef | Web of Science | Medline14
Staessen JA ,Fagard R ,Thijs L , et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-764
CrossRef | Web of Science | Medline15
Fagard R ,Brguljan J ,Thijs L ,Staessen J . Prediction of the actual awake and asleep blood pressures by various methods of 24-h pressure analysis. J Hypertens 1996;14:557-563
CrossRef | Web of Science | Medline16
Pickering TG . How should the diurnal changes of blood pressure be expressed? Am J Hypertens 1995;8:681-682
CrossRef | Web of Science | Medline17
O'Brien E ,Sheridan J ,O'Malley K . Dippers and non-dippers. Lancet 1988;2:397-397
CrossRef | Web of Science | Medline18
Verdecchia P ,Schillaci G ,Borgioni C ,Ciucci A ,Gattobigio R ,Porcellati C . Nocturnal pressure is the true pressure. Blood Press Monit 1996;1:Suppl 2:S81-S8519
Verdecchia P ,Schillaci G ,Gatteschi C , et al. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation 1993;88:986-992
Web of Science | Medline20
Verdecchia P ,Porcellati C ,Schillaci G , et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801[Erratum, Hypertension 1995;25:462.]
Web of Science | Medline21
Ohkubo T ,Hozawa A ,Yamaguchi J , et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002;20:2183-2189
CrossRef | Web of Science | Medline22
Ohkubo T ,Imai Y ,Tsuji I , et al. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study. Hypertension 1998;32:255-259
Web of Science | Medline23
Fagard RH ,Staessen JA ,Thijs L . Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 1997;29:22-29
Web of Science | Medline24
De Henauw S ,De Bacquer D ,Fonteyne W ,Stam M ,Kornitzer M ,De Backer G . Trends in the prevalence, detection, treatment and control of arterial hypertension in the Belgian adult population. J Hypertens 1998;16:277-284
CrossRef | Web of Science | Medline25
Mancia G ,Bombelli M ,Lanzarotti A , et al. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Arch Intern Med 2002;162:582-586
CrossRef | Web of Science | Medline26
Staessen JA ,Byttebier G ,Buntinx F ,Celis H ,O'Brien ET ,Fagard R . Antihypertensive treatment based on conventional or ambulatory blood pressure measurement: a randomised controlled trial. JAMA 1997;278:1065-1072
CrossRef | Web of Science | Medline27
Chobanian AV ,Bakris GL ,Black HR , et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC7 Report. JAMA 2003;289:2560-2572
CrossRef | Web of Science | Medline
- Citing Articles (265)
Citing Articles
1
George S. Stergiou, Gianfranco Parati. (2012) Home blood pressure monitoring may make office measurements obsolete. Journal of Hypertension 30:3, 463-465
CrossRef2
Denes Pall, Istvan Kiss, Eva Katona. (2012) Importance of Ambulatory Blood Pressure Monitoring in Adolescent Hypertension. Kidney and Blood Pressure Research 35:2, 129-134
CrossRef3
Thomas Weber, Carmel McEniery, Ian Wilkinson, Giuseppe Schillaci, Maria Lorenza Muiesan, Robert Zweiker, Cristina Giannattasio, Kai Mortensen, Johannes Baulmann, Arno Schmidt-Trucksäss, Siegfried Wassertheurer. (2012) Relationship between 24 h ambulatory central blood pressure and left ventricular mass – Rationale and design of a prospective multicenter study. Artery Research
CrossRef4
María Cecilia Salgueiro, Xènia Martín Fernández, Ernest Vinyoles Bargalló. (2012) Varón con enfermedad renal crónica. ¿Normotenso?. FMC - Formación Médica Continuada en Atención Primaria 19:1, 16-19
CrossRef5
Thomas Sehestedt, Jørgen Jeppesen, Tine W. Hansen, Susanne Rasmussen, Kristian Wachtell, Hans Ibsen, Christian Torp-Pedersen, Michael H. Olsen. (2012) Can ambulatory blood pressure measurements substitute assessment of subclinical cardiovascular damage?. Journal of Hypertension1
CrossRef6
Yuichirou Yano, Satoshi Hoshide, Motohiro Shimizu, Kazuo Eguchi, Joji Ishikawa, Shizukiyo Ishikawa, Kazuyuki Shimada, Kazuomi Kario. (2011) Association of Home and Ambulatory Blood Pressure Changes With Changes in Cardiovascular Biomarkers During Antihypertensive Treatment. American Journal of Hypertension
CrossRef7
Ramachandran Meenakshisundaram, Doraswami Babuvinish, Martin Grootveld, Chinnasamy Rajendiran, Ponniah Thirumalaikolundusubramanian. (2011) Status of End Organs in Newly Detected Rural Essential Hypertensives: A Study from Southern India. Clinical and Experimental Hypertension1-8
CrossRef8
Ramón C. Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández. (2011) Sleep-Time Blood Pressure as a Therapeutic Target for Cardiovascular Risk Reduction in Type 2 Diabetes. American Journal of Hypertension
CrossRef9
Cynthia S. Bell, Tim S. Poffenbarger, Joshua A. Samuels. (2011) Ambulatory blood pressure status in children: comparing alternate limit sources. Pediatric Nephrology 26:12, 2211-2217
CrossRef10
Geoffrey A. Head, Barry P. McGrath, Anastasia S. Mihailidou, Mark R. Nelson, Markus P. Schlaich, Michael Stowasser, Arduino A. Mangoni, Diane Cowley, Mark A. Brown, Lee-Anne Ruta, Alison Wilson. (2011) Ambulatory blood pressure monitoring in Australia. Journal of Hypertension1
CrossRef11
Ramón C. Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández. (2011) Sleep-Time Blood Pressure and the Prognostic Value of Isolated-Office and Masked Hypertension. American Journal of Hypertension
CrossRef12
Kageumi Takeno, Tomoya Mita, Shiho Nakayama, Hiromasa Goto, Koji Komiya, Hiroko Abe, Fuki Ikeda, Tomoaki Shimizu, Akio Kanazawa, Takahisa Hirose, Ryuzo Kawamori, Hirotaka Watada. (2011) Masked Hypertension, Endothelial Dysfunction, and Arterial Stiffness in Type 2 Diabetes Mellitus: A Pilot Study. American Journal of Hypertension
CrossRef13
T Quinaglia, L C Martins, V N Figueiredo, R C Santos, J C Yugar-Toledo, J F Vilela Martin, C Demacq, E Pimenta, D A Calhoun, H Moreno. (2011) Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension. Journal of Human Hypertension 25:11, 656-664
CrossRef14
Jürgen Scholze, Peter Bramlage, Peter Trenkwalder, Reinhold Kreutz. (2011) Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure. Expert Opinion on Pharmacotherapy1-9
CrossRef15
Leopoldo Raij, Brent M. Egan, Dion H. Zappe, Das Purkayastha, Rita Samuel, James R. Sowers. (2011) Office and Ambulatory Blood Pressure-Lowering Effects of Combination Valsartan/Hydrochlorothiazide vs Hydrochlorothiazide-Based Therapy in Obese, Hypertensive Patients. The Journal of Clinical Hypertension 13:10, 731-738
CrossRef16
Riitta-Liisa Vasunta, Y. Antero Kesäniemi, Antti Ylitalo, Olavi Ukkola. (2011) Nondipping Pattern and Carotid Atherosclerosis in a Middle-Aged Population: OPERA Study. American Journal of Hypertension
CrossRef17
Ikechi G Okpechi, Brian L Rayner. (2011) Impact of recent landmark clinical trials on hypertension treatment. Clinical Investigation 1:8, 1141-1154
CrossRef18
Luis M. Ruilope. (2011) Telmisartan for the management of patients at high cardiovascular risk. Current Medical Research and Opinion 27:8, 1673-1682
CrossRef19
Rafał Poręba, Paweł Gać, Małgorzata Poręba, Jolanta Antonowicz-Juchniewicz, Ryszard Andrzejak. (2011) Relationship between occupational exposure to lead and local arterial stiffness and left ventricular diastolic function in individuals with arterial hypertension. Toxicology and Applied Pharmacology 254:3, 342-348
CrossRef20
M. Doménech Feria-Carot, J. Sobrino Martínez. (2011) Hipertensión nocturna. Hipertensión y Riesgo Vascular 28:4, 143-148
CrossRef21
Sarah Israel, Ariel Israel, Iddo Z. Ben-Dov, Michael Bursztyn. (2011) The Morning Blood Pressure Surge and All-Cause Mortality in Patients Referred for Ambulatory Blood Pressure Monitoring. American Journal of Hypertension 24:7, 796-801
CrossRef22
Y-T Kao, C-C Huang, H-B Leu, T-C Wu, P-H Huang, S-J Lin, J-W Chen. (2011) Ambulatory pulse pressure as a novel predictor for long-term prognosis in essential hypertensive patients. Journal of Human Hypertension 25:7, 444-450
CrossRef23
Lawrence R Krakoff. (2011) Home blood pressure for the management of hypertension: will it become the new standard of practice?. Expert Review of Cardiovascular Therapy 9:6, 745-751
CrossRef24
Emmanuel A. Andreadis, Gerasimos D. Agaliotis, Epameinondas T. Angelopoulos, Athanasios P. Tsakanikas, Ioannis A. Chaveles, George P. Mousoulis. (2011) Automated Office Blood Pressure and 24-h Ambulatory Measurements are Equally Associated With Left Ventricular Mass Index. American Journal of Hypertension 24:6, 661-666
CrossRef25
Manish D. Sinha, Caroline J. Booth, Christopher J.D. Reid. (2011) Factors affecting success of blood pressure measurements during ambulatory blood pressure monitoring in children with renal disease. Cardiology in the Young 21:03, 310-316
CrossRef26
Thomas Sehestedt, Tine W Hansen, Yan Li, Tom Richart, Jose Boggia, Masahiro Kikuya, Lutgarde Thijs, Katarzyna Stolarz-Skrzypek, Edoardo Casiglia, Valérie Tikhonoff, Sofia Malyutina, Yuri Nikitin, Kristina Björklund-Bodegård, Tatiana Kuznetsova, Takayoshi Ohkubo, Lars Lind, Christian Torp-Pedersen, Jørgen Jeppesen, Hans Ibsen, Yutaka Imai, Jiguang Wang, Edgardo Sandoya, Kalina Kawecka-Jaszcz, Jan A Staessen. (2011) Are blood pressure and diabetes additive or synergistic risk factors? Outcome in 8494 subjects randomly recruited from 10 populations. Hypertension Research 34:6, 714-721
CrossRef27
Yener Koc, Abdulkadir Unsal, Hasan Kayabasi, Erkan Oztekin, Tamer Sakaci, Elbis Ahbap, Murvet Yilmaz, Ali Oguz Akgun. (2011) Impact of Volume Status on Blood Pressure and Left Ventricle Structure in Patients Undergoing Chronic Hemodialysis. Renal Failure 33:4, 377-381
CrossRef28
Raymond Townsend, Neville Bittar, Jeffrey Rosen, William Smith, Andrea Ramsay, Steven G. Chrysant, Robert Weiss, Aldina Pivodic, Brigitte Duquesroix, Jacques Djian. (2011) Blood Pressure Effects of Naproxcinod in Hypertensive Patients. The Journal of Clinical Hypertension 13:5, 376-384
CrossRef29
M. Camafort Babkowski. (2011) Monitorización ambulatoria de la presión arterial e insuficiencia cardiaca. Hipertensión y Riesgo Vascular 28:3, 102-107
CrossRef30
C Tsioufis, I Andrikou, C Thomopoulos, D Syrseloudis, G Stergiou, C Stefanadis. (2011) Increased nighttime blood pressure or nondipping profile for prediction of cardiovascular outcomes. Journal of Human Hypertension 25:5, 281-293
CrossRef31
L FitzGerald, C Ottaviani, I B Goldstein, D Shapiro. (2011) Effects of dipping and psychological traits on morning surge in blood pressure in healthy people. Journal of Human Hypertension
CrossRef32
M E Ernst, G S Sezate, W Lin, C A Weber, J D Dawson, B L Carter, G R Bergus. (2011) Indication-specific 6-h systolic blood pressure thresholds can approximate 24-h determination of blood pressure control. Journal of Human Hypertension 25:4, 250-255
CrossRef33
B. Vaisse, P. Lantelme, X. Girerd, M. Azizi, J.-J. Mourad, J.-P. Baguet, Rédigé par P. Sabouret. (2011) Flashes d’actualité - HTA/Vasculaire. Archives des Maladies du Coeur et des Vaisseaux - Pratique 2011, S10-S14
CrossRef34
Giuseppe Schillaci, Giacomo Pucci. (2011) Central and 24-h blood pressure: dwarfs standing upon the shoulders of giants?. Journal of Hypertension 29:3, 430-433
CrossRef35
A. Burgaz, L. Byberg, S. Rautiainen, N. Orsini, N. Håkansson, J. Ärnlöv, J. Sundström, L. Lind, H. Melhus, K. Michaëlsson, A. Wolk. (2011) Confirmed hypertension and plasma 25(OH)D concentrations amongst elderly men. Journal of Internal Medicine 269:2, 211-218
CrossRef36
Cristiane B Leitão, Ticiana C Rodrigues, Caroline K Kramer, Luciana R Schreiner, Lana C Pinto, Eliza D Ricardo, Karina Biavatti, Luís H Canani, Jorge L Gross. (2011) Which patients with diabetes should undergo ambulatory blood pressure monitoring?. Journal of Hypertension 29:2, 236-241
CrossRef37
M. Godwin, R. Birtwhistle, D. Delva, M. Lam, I. Casson, S. MacDonald, R. Seguin. (2011) Manual and automated office measurements in relation to awake ambulatory blood pressure monitoring. Family Practice 28:1, 110-117
CrossRef38
Gregory Vyssoulis, Eva Karpanou, Stella-Maria Kyvelou, Vanessa Tzamou, Andreas Triantafyllou, George Theodosiadis, Christodoulos Stefanadis. (2011) Ambulatory blood pressure profile in hypertensive patients with β-thalassemia minor. Hypertension Research 34:2, 253-256
CrossRef39
Sung-Ji Park, Jeong Bae Park, Dong-Ju Choi, Ho Joong Youn, Chang Gyu Park, Young Keun Ahn, Joon-Han Shin, Dong Woon Kim, Se Joong Rim, Jang Ho Bae, Hyun Young Park, The Korean Hypertension Research Ne. (2011) Detection of Masked Hypertension and the `Mask Effect' in Patients With Well-Controlled Office Blood Pressure. Circulation Journal 75:2, 357-365
CrossRef40
Robert M Carey. 2011. Pathophysiology of Primary Hypertension. .
CrossRef41
Terry Young, F. Javier Nieto, Shahrokh Javaheri. 2011. Systemic and Pulmonary Hypertension in Obstructive Sleep Apnea. , 1381-1392.
CrossRef42
Jae-Joong Kim. (2011) Cardiovascular Diseases after Solid Organ Transplantation. The Journal of the Korean Society for Transplantation 25:4, 229
CrossRef43
Mehmet Kayrak, Ahmet Bacaksiz, Mehmet Akif Vatankulu, Selim S. Ayhan, Zeynettin Kaya, Hatem Ari, Osman Sonmez, Hasan Gok. (2010) Exaggerated Blood Pressure Response to Exercise –– A New Portent of Masked Hypertension. Clinical and Experimental Hypertension 32:8, 560-568
CrossRef44
Bernard Waeber, Jean-Jacques Mourad, Eoin O’Brien. (2010) Nighttime Blood Pressure: A Target for Therapy?. Current Hypertension Reports 12:6, 474-479
CrossRef45
N McGowan, P L Padfield. (2010) Self blood pressure monitoring: a worthy substitute for ambulatory blood pressure?. Journal of Human Hypertension 24:12, 801-806
CrossRef46
Stella Stabouli, Sofia Papakatsika, Vasilios Kotsis. (2010) Hypothyroidism and hypertension. Expert Review of Cardiovascular Therapy 8:11, 1559-1565
CrossRef47
José Mesquita-Bastos, Susana Bertoquini, Jorge Polónia. (2010) Cardiovascular prognostic value of ambulatory blood pressure monitoring in a Portuguese hypertensive population followed up for 8.2 years. Blood Pressure Monitoring 15:5, 240-246
CrossRef48
Yves Lacourcière, Luc Poirier, Jean Lefebvre, Stuart A. Ross, Frans H. Leenen. (2010) Increasing the doses of both diuretics and angiotensin receptor blockers is beneficial in subjects with uncontrolled systolic hypertension. Canadian Journal of Cardiology 26:8, e313-e319
CrossRef49
Paul E. Drawz, Noah Rosenthal, Denise C. Babineau, Mahboob Rahman. (2010) Nighttime hospital blood pressure – a predictor of death, ESRD, and decline in GFR. Renal Failure 32:9, 1036-1043
CrossRef50
İsmail Erden, Emine Cakcak Erden, Hakan Özhan, Subhan Yalçin, Cengiz Basar, Mesut Aydin. (2010) Effect of dipping status on QRS morphology in patients with hypertension. Blood Pressure Monitoring 15:5, 247-250
CrossRef51
Gbenga Ogedegbe, Charles Agyemang, Joseph E. Ravenell. (2010) Masked Hypertension: Evidence of the Need to Treat. Current Hypertension Reports 12:5, 349-355
CrossRef52
Jiri Charvat, Jaromir Chlumsky, Marcela Szabo, Eva Zakovicova, Vaclav Zamrazil. (2010) The association of masked hypertension in treated type 2 diabetic patients with carotid artery IMT. Diabetes Research and Clinical Practice 89:3, 239-242
CrossRef53
Fabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia. (2010) Masked Hypertension: Evaluation, Prognosis, and Treatment. American Journal of Hypertension 23:9, 941-948
CrossRef54
Katarzyna Stolarz-Skrzypek, Lutgarde Thijs, Tom Richart, Yan Li, Tine W Hansen, José Boggia, Tatiana Kuznetsova, Masahiro Kikuya, Kalina Kawecka-Jaszcz, Jan A Staessen. (2010) Blood pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome. Hypertension Research 33:8, 757-766
CrossRef55
Gianfranco Parati, Grzegorz Bilo. (2010) Evening administration of antihypertensive drugs: filling a knowledge gap. Journal of Hypertension 28:7, 1390-1392
CrossRef56
Hani M. Wadei, Stephen C. Textor. (2010) Hypertension in the kidney transplant recipient. Transplantation Reviews 24:3, 105-120
CrossRef57
Philip A. Kithas, Mark A. Supiano. (2010) Hypertension and Chronic Kidney Disease in the Elderly. Advances in Chronic Kidney Disease 17:4, 341-347
CrossRef58
Philip A. Kithas, Mark A. Supiano. (2010) Spironolactone and Hydrochlorothiazide Decrease Vascular Stiffness and Blood Pressure in Geriatric Hypertension. Journal of the American Geriatrics Society 58:7, 1327-1332
CrossRef59
Peter U. Feig, Sophie Roy, Robert J. Cody. (2010) Antihypertensive drug development: current challenges and future opportunities. Journal of the American Society of Hypertension 4:4, 163-173
CrossRef60
Daniel Sabater-Hernández, Oussamah Fikri-Benbrahim, María José Faus. (2010) Utilidad de la monitorización ambulatoria de la presión arterial en la toma de decisiones clínicas. Medicina Clínica 135:1, 23-29
CrossRef61
Thomas Dieterle, Joerg-Peter Sigle, Gunar Bengel, Gerrit Kiefer, Verena Brenneisen, Benedict Martina. (2010) Cardiovascular risk stratification in unselected primary care patients with newly detected arterial hypertension. Hypertension Research 33:6, 607-615
CrossRef62
Rukiye Pinar, Sıddıka Ataalkin, Roger Watson. (2010) The effect of crossing legs on blood pressure in hypertensive patients. Journal of Clinical Nursing 19:9-10, 1284-1288
CrossRef63
Randy Wexler. (2010) Ambulatory Blood Pressure Monitoring in Primary Care. Southern Medical Journal 103:5, 447-452
CrossRef64
José Mesquita Bastos, Susana Bertoquini, Jorge Polónia. (2010) Prognostic Value of Subdivisions of Nighttime Blood Pressure Fall in Hypertensives Followed Up for 8.2 Years. Does Nondipping Classification Need to Be Redefined?. The Journal of Clinical Hypertension
CrossRef65
John Kammeyer-Mueller, Piers D. G. Steel, Alex Rubenstein. (2010) The Other Side of Method Bias: The Perils of Distinct Source Research Designs. Multivariate Behavioral Research 45:2, 294-321
CrossRef66
Robert H. Mak, George Bakris. (2010) Pediatrics: Masked hypertension: a risk factor in children with CKD. Nature Reviews Nephrology 6:3, 132-134
CrossRef67
Peter M Rothwell. (2010) Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. The Lancet 375:9718, 938-948
CrossRef68
George A Kelley, Kristi S Kelley. (2010) Isometric handgrip exercise and resting blood pressure: a meta-analysis of randomized controlled trials. Journal of Hypertension 28:3, 411-418
CrossRef69
Peter W de Leeuw. (2010) Does nocturnal blood pressure impair renal function?. Journal of Hypertension 28:3, 430-431
CrossRef70
John B Kostis. (2010) Antihypertensive Therapy With CCB/ARB Combination in Older Individuals: Focus on Amlodipine/Valsartan Combination. American Journal of Therapeutics 17:2, 188-196
CrossRef71
Debbie L. Cohen, Raymond R. Townsend. (2010) Is Ambulatory Blood Pressure Monitoring Finally Catching On?. The Journal of Clinical Hypertension 12:3, 193-194
CrossRef72
Thomas Hedner, Sverre Kjeldsen, Krzysztof Narkiewicz. (2010) Implementation of 24-hour Blood Pressure Control. Blood Pressure 19:s1, 3-4
CrossRef73
Daniel K. Nishijima, Lorenzo Paladino, Richard Sinert. (2010) Routine testing in patients with asymptomatic elevated blood pressure in the ED. The American Journal of Emergency Medicine 28:2, 235-242
CrossRef74
P Palatini, W Jung, E Shlyakhto, J Botha, C Bush, D L Keefe. (2010) Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study. Journal of Human Hypertension 24:2, 93-103
CrossRef75
Petteri Hovi, Sture Andersson, Katri Räikkönen, Sonja Strang-Karlsson, Anna-Liisa Järvenpää, Johan G. Eriksson, Anu-Katriina Pesonen, Kati Heinonen, Riikka Pyhälä, Eero Kajantie. (2010) Ambulatory Blood Pressure in Young Adults with Very Low Birth Weight. The Journal of Pediatrics 156:1, 54-59.e1
CrossRef76
M. Gorostidi, J. Segura, A. de la Sierra. (2010) Hipertensión arterial nocturna. Hipertensión y Riesgo Vascular 27, 26-33
CrossRef77
J M Neutel, D H G Smith, A H Gradman. (2010) Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I–II hypertension. Journal of Human Hypertension 24:1, 64-73
CrossRef78
Soon-Gil Kim. (2010) Clinical Implications of Ambulatory and Home Blood Pressure Monitoring. Korean Circulation Journal 40:9, 423
CrossRef79
A. de la Sierra. (2010) Justificación, objetivos y metodología del estudio EVOLVE: del análisis transversal al estudio longitudinal. Hipertensión y Riesgo Vascular 27, 64-68
CrossRef80
Michele Bombelli, Rita Facchetti, Stefano Carugo, Fabiana Madotto, Francesca Arenare, Fosca Quarti-Trevano, Anna Capra, Cristina Giannattasio, Raffaella DellʼOro, Guido Grassi, Roberto Sega, Giuseppe Mancia. (2009) Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. Journal of Hypertension 27:12, 2458-2464
CrossRef81
Dénes Páll, Mária Juhász, Éva Katona, Szabolcs Lengyel, Éva Komonyi, Béla Fülesdi, György Paragh. (2009) Az ambuláns vérnyomás-monitorozás jelentősége serdülőkorban. Orvosi Hetilap 150:49, 2211-2217
CrossRef82
Nimrta Ghuman, Patrick Campbell, William B. White. (2009) Role of ambulatory and home blood pressure recording in clinical practice. Current Cardiology Reports 11:6, 414-421
CrossRef83
R H Fagard, L Thijs, J A Staessen, D L Clement, M L De Buyzere, D A De Bacquer. (2009) Night–day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. Journal of Human Hypertension 23:10, 645-653
CrossRef84
Neil J. McGowan, Kathleen Gough, Paul L. Padfield. (2009) Nocturnal dipping is reproducible in the long term. Blood Pressure Monitoring 14:5, 185-189
CrossRef85
B Williams, Y Lacourcière, H Schumacher, P Gosse, J M Neutel. (2009) Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials. Journal of Human Hypertension 23:9, 610-619
CrossRef86
Denis L. Clement. (2009) Treatment of hypertension in patients with peripheral arterial disease: An update. Current Hypertension Reports 11:4, 271-276
CrossRef87
José Ma Lobos Bejarano, Miguel Angel Royo-Bordonada, Carlos Brotons, Luís Álvarez-Sala, Pedro Armario, Antonio Maiques, Dídac Mauricio, Susana Sans, Fernando Villar, Angel Lizcano, Antonio Gil-Núñez, Fernando de Álvaro, Pedro Conthe, Emilio Luengo, Alfonso del Río, Olga Cortés, Ana de Santiago, Miguel A. Vargas, Mercedes Martínez, Vicenta Lizarbe. (2009) Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008. Atención Primaria 41:8, 463.e1-463.e24
CrossRef88
Robert H Fagard. (2009) Dipping pattern of nocturnal blood pressure in patients with hypertension. Expert Review of Cardiovascular Therapy 7:6, 599-605
CrossRef89
Deborah P. Jones, Phyllis A. Richey, Bruce S. Alpert. (2009) Comparison of ambulatory blood pressure reference standards in children evaluated for hypertension. Blood Pressure Monitoring 14:3, 103-107
CrossRef90
Veeran Subramaniam, Gregory YH Lip. (2009) Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke. Expert Review of Cardiovascular Therapy 7:6, 703-713
CrossRef91
J.M. Lobos, M.Á. Royo-Bordonada, C. Brotons, L. Álvarez-Sala, P. Armario, A. Maiques, D. Mauricio, S. Sans, F. Villar, Á. Lizcano, A. Gil-Núñez, F. de Álvaro, P. Conthe, E. Luengo, A. del Río, O. Cortés, A. de Santiago, M.A. Varga, M. Martínez, V. Lizarbe. (2009) Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008. Revista Clínica Española 209:6, 279-302
CrossRef92
José M. Lobos, Miguel Ángel Royo-Bordonada, Carlos Brotons, Luis Álvarez-Sala, Pedro Armario, Antonio Maiques, Dídac Mauricio, Susana Sans, Fernando Villar, Ángel Lizcano, Antonio Gil-Núñez, Fernando de Álvaro, Pedro Conthe, Emilio Luengo, Alfonso del Río, Olga Cortés, Ana de Santiago, Miguel A. Vargas, Mercedes Martínez, Vicenta Lizarbe. (2009) Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008. Clínica e Investigación en Arteriosclerosis 21:3, 124-150
CrossRef93
Zofia Dzielińska, Aleksander Prejbisz, Magdalena Makowiecka-Cieśla, Andrzej Januszewicz, Paweł Tyczyński, Marcin Demkow, Tomasz Zieliński, Jacek Kądziela, Elżbieta Florczak, Witold Rużyłło. (2009) The 24-h blood pressure measurement may predict mortality and cardiovascular events in hypertensive patients with coronary artery disease. Blood Pressure Monitoring 14:3, 99-102
CrossRef94
Eamon Dolan, Alice V Stanton, Simon Thom, Mark Caulfield, Neil Atkins, Gordon McInnes, David Collier, Patrick Dicker, Eoin OʼBrien. (2009) Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients – an Anglo-Scandinavian cardiac outcomes trial substudy. Journal of Hypertension 27:4, 876-885
CrossRef95
Julie A. Johnson, Eric Boerwinkle, Issam Zineh, Arlene B. Chapman, Kent Bailey, Rhonda M. Cooper-DeHoff, John Gums, R. Whit Curry, Yan Gong, Amber L. Beitelshees, Gary Schwartz, Stephen T. Turner. (2009) Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study. American Heart Journal 157:3, 442-449
CrossRef96
Angela J Woodiwiss, Nomonde Molebatsi, Muzi J Maseko, Elena Libhaber, Carlos Libhaber, Olebogeng HI Majane, Janice Paiker, Patrick Dessein, Richard Brooksbank, Pinhas Sareli, Gavin R Norton. (2009) Nurse-recorded auscultatory blood pressure at a single visit predicts target organ changes as well as ambulatory blood pressure. Journal of Hypertension 27:2, 287-297
CrossRef97
Timothy Krauss, Heribert Schunkert. (2009) Management der arteriellen Hypertonie (ESC-Leitlinie 2007/DHL-Leitlinie 2008). Herz 34:1, 15-20
CrossRef98
Rajiv Agarwal, Aldo J. Peixoto, Sergio F.F. Santos, Carmine Zoccali. (2009) Out-of-office blood pressure monitoring in chronic kidney disease. Blood Pressure Monitoring 14:1, 2-11
CrossRef99
Juan Diego Mediavilla García, Celia Fernández-Torres, Ascensión Arroyo Nieto, Manuela Expósito Ruiz, Juan Jiménez-Alonso. (2009) Estudio de la variabilidad de la presión arterial en pacientes con hipertensión arterial y su relación con el filtrado glomerular. Medicina Clínica 132:5, 180-183
CrossRef100
D Conen, P Tschudi, B Martina. (2009) Twenty-four hour ambulatory blood pressure for the management of antihypertensive treatment: a randomized controlled trial. Journal of Human Hypertension 23:2, 122-129
CrossRef101
Andrea Ungar, Giuseppe Pepe, Lorella Lambertucci, Angela Fedeli, Matteo Monami, Edoardo Mannucci, Luciano Gabbani, Giulio Masotti, Niccolò Marchionni, Mauro Di Bari. (2009) Low Diastolic Ambulatory Blood Pressure Is Associated with Greater All-Cause Mortality in Older Patients with Hypertension. Journal of the American Geriatrics Society 57:2, 291-296
CrossRef102
J.R Fernandez, R.C Hermida, A Mojon. (2009) Chronobiological analysis techniques. Application to blood pressure. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 367:1887, 431-445
CrossRef103
Francesco Portaluppi, Pietro Cortelli, Giovanna Calandra Buonaura, Michael H Smolensky, Fabio Fabbian. (2009) DO RESTLESS LEGS SYNDROME (RLS) AND PERIODIC LIMB MOVEMENTS OF SLEEP (PLMS) PLAY A ROLE IN NOCTURNAL HYPERTENSION AND INCREASED CARDIOVASCULAR RISK OF RENALLY IMPAIRED PATIENTS?. Chronobiology International 26:6, 1206-1221
CrossRef104
Dong-Hyeon Lee, Sang-Hyun Ihm, Ho-Joong Youn, Yun-Seok Choi, Chan-Seok Park, Chul-Soo Park, Jong-Min Lee, Hee-Youl Kim, Yong-Seog Oh, Wook-Sung Chung, Ki-Bae Seung, Jae-Hyung Kim. (2009) Age is an Independent Risk Factor for the Early Morning Blood Pressure Surge in Patients Never-Treated for Hypertension. Korean Circulation Journal 39:8, 322
CrossRef105
Robert H. Fagard, Lutgarde Thijs, Jan A. Staessen, Denis L. Clement, Marc L. De Buyzere, Dirk A. De Bacquer. (2008) Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease. Blood Pressure Monitoring 13:6, 325-332
CrossRef106
Marko P. O. Virtanen, Tiit Kööbi, Väinö M. H. Turjanmaa, Silja Majahalme, Martti T. Tuomisto, Tuomo Nieminen, Mika Kähönen. (2008) Predicting arterial stiffness with ambulatory blood pressure: an 11-year follow-up. Clinical Physiology and Functional Imaging 28:6, 378-383
CrossRef107
Thomas G. Pickering, William B. White, . (2008) ASH Position Paper: Home and Ambulatory Blood Pressure Monitoring�When and How to Use Self (Home) and Ambulatory Blood Pressure Monitoring. The Journal of Clinical Hypertension 10:11, 850-855
CrossRef108
DEBORAH P. JONES, PHYLLIS A. RICHEY, BRUCE S. ALPERT, RONGLING LI. (2008) Serum Uric Acid and Ambulatory Blood Pressure in Children With Primary Hypertension. Pediatric Research 64:5, 556-561
CrossRef109
Kazuyuki Shimada, Toshiro Fujita, Sadayoshi Ito, Hiroaki Naritomi, Toshio Ogihara, Kazuaki Shimamoto, Heizo Tanaka, Nobuo Yoshiike. (2008) The Importance of Home Blood Pressure Measurement for Preventing Stroke and Cardiovascular Disease in Hypertensive Patients: A Sub-Analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study, a Prospective Nationwide Observational Study. Hypertension Research 31:10, 1903-1911
CrossRef110
Rafael T. Krmar, Ulla B. Berg. (2008) Blood Pressure Control in Hypertensive Pediatric Renal Transplants: Role of Repeated ABPM Following Transplantation. American Journal of Hypertension 21:10, 1093-1099
CrossRef111
Valérie Gaborieau, Nicolas Delarche, Philippe Gosse. (2008) Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage. Journal of Hypertension 26:10, 1919-1927
CrossRef112
Willem J. Verberk, Alphons G.H. Kessels, Peter W. de Leeuw. (2008) Prevalence, Causes, and Consequences of Masked Hypertension: A Meta-analysis. American Journal of Hypertension 21:9, 969-975
CrossRef113
Guillaume Bobrie, Pierre Clerson, Joël Ménard, Nicolas Postel-Vinay, Gilles Chatellier, Pierre-François Plouin. (2008) Masked hypertension: a systematic review. Journal of Hypertension 26:9, 1715-1725
CrossRef114
Roberto Dischinger Miranda, Décio Mion, Joăo Carlos Rocha, Oswaldo Kohlmann, Marco Antonio Mota Gomes, José Francisco Kerr Saraiva, Celso Amodeo, Bráulio Luna Filho. (2008) An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: The assessment of combination therapy of amlodipine/ramipril (ATAR) study. Clinical Therapeutics 30:9, 1618-1628
CrossRef115
Russell L. Silverstein, C. Venkata S. Ram. (2008) Resistant Hypertension. Primary Care: Clinics in Office Practice 35:3, 501-513
CrossRef116
Paolo Palatini. (2008) Ambulatory blood pressure monitoring in clinical practice: is being superior good enough?. Journal of Hypertension 26:7, 1300-1302
CrossRef117
David Conen, Fabian Bamberg. (2008) Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. Journal of Hypertension 26:7, 1290-1299
CrossRef118
Barbara Strasser, Paul Haber, Christoph Strehblow, Edmund Cauza. (2008) The benefit of strength training on arterial blood pressure in patients with type 2 diabetes mellitus measured with ambulatory 24-hour blood pressure systems. Wiener Medizinische Wochenschrift 158:13-14, 379-384
CrossRef119
Iddo Z. Ben-Dov, Judith Mekler, Michael Bursztyn. (2008) Sex Differences in Ambulatory Blood Pressure Monitoring. The American Journal of Medicine 121:6, 509-514
CrossRef120
Alex Roca-Cusachs, Joaquín Aracil-Vilar, Carlos Calvo-Gómez, José-Vicente Vaquer-Pérez, Félix Laporta-Crespo, María-José Rojas-Serrano, Antonio Guglietta, Savion Gropper, . (2008) Clinical Effects of Torasemide Prolonged Release in Mild-to-Moderate Hypertension: A Randomized Noninferiority Trial Versus Torasemide Immediate Release. Cardiovascular Therapeutics 26:2, 91-100
CrossRef121
J.-L. Elghozi. (2008) Variabilité à court terme de la pression artérielle : physiologie et pharmacologie. Annales Pharmaceutiques Françaises 66:3, 158-168
CrossRef122
Giorgio Recordati, Alberto Zanchetti. (2008) The 24 h blood pressure-R–R interval relation in ambulatory monitoring. Autonomic Neuroscience 139:1-2, 68-77
CrossRef123
Thomas G. Pickering, William B. White. (2008) When and how to use self (home) and ambulatory blood pressure monitoring. Journal of the American Society of Hypertension 2:3, 119-124
CrossRef124
Iddo Z Ben-Dov, Jeremy D Kark, Judith Mekler, Efrat Shaked, Michael Bursztyn. (2008) The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study. Journal of Hypertension 26:4, 699-705
CrossRef125
C. B. Leitão, L. H. Canani, C. K. Kramer, M. Moehlecke, L. C. Pinto, E. D. Ricardo, A. F. Pinotti, J. L. Gross. (2008) Blood pressure means rather than nocturnal dipping pattern are related to complications in Type 2 diabetic patients. Diabetic Medicine 25:3, 308-313
CrossRef126
Phyllis A. Richey, Thomas G. DiSessa, Margaret C. Hastings, Grant W. Somes, Bruce S. Alpert, Deborah P. Jones. (2008) Ambulatory Blood Pressure and Increased Left Ventricular Mass in Children at Risk for Hypertension. The Journal of Pediatrics 152:3, 343-348
CrossRef127
Gaurav Mathur, Rachana Prasad, Anne Robinson, Erwin Rodrigues, Peter Wong. (2008) Is the use of ABPM justified in patients on 1 or 2 antihypertensive medications?. International Journal of Cardiology 125:1, 118-119
CrossRef128
Alexander G Logan, Andrea Dunai, Warren J McIsaac, M Jane Irvine, Andras Tisler. (2008) Attitudes of primary care physicians and their patients about home blood pressure monitoring in Ontario. Journal of Hypertension 26:3, 446-452
CrossRef129
Kazuo Eguchi, Satoshi Hoshide, Joji Ishikawa, Shizukiyo Ishikawa, Thomas G. Pickering, William Gerin, Gbenga Ogedegbe, Joseph E. Schwartz, Kazuyuki Shimada, Kazuomi Kario. (2008) Cardiovascular prognosis of sustained and white-coat hypertension in patients with type 2 diabetes mellitus. Blood Pressure Monitoring 13:1, 15-20
CrossRef130
Alfonso TATASCIORE, Marco ZIMARINO, Giulia RENDA, Maria ZURRO, Manola SOCCIO, Concetta PRONTERA, Michele EMDIN, Mariarosaria FLACCO, Giuseppe SCHILLACI, Raffaele DE CATERINA. (2008) Awake Blood Pressure Variability, Inflammatory Markers and Target Organ Damage in Newly Diagnosed Hypertension. Hypertension Research 31:12, 2137-2146
CrossRef131
Claudia R.L. CARDOSO, Nathalie C. LEITE, Ludmilla FREITAS, Saulo B. DIAS, Elizabeth S. MUXFELD, Gil F. SALLES. (2008) Pattern of 24-Hour Ambulatory Blood Pressure Monitoring in Type 2 Diabetic Patients with Cardiovascular Dysautonomy. Hypertension Research 31:5, 865-872
CrossRef132
Lawrence R. Krakoff. 2008. Decisions for Management of High Blood Pressure: A Perspective. , 567-574.
CrossRef133
Shiho NAKAYAMA, Hirotaka WATADA, Tomoya MITA, Fuki IKEDA, Tomoaki SHIMIZU, Hiroshi UCHINO, Yoshio FUJITANI, Takahisa HIROSE, Ryuzo KAWAMORI. (2008) Comparison of Effects of Olmesartan and Telmisartan on Blood Pressure and Metabolic Parameters in Japanese Early-Stage Type-2 Diabetics with Hypertension. Hypertension Research 31:1, 7-13
CrossRef134
Mark L. De Buyzere, Denis L. Clement. (2008) Management of Hypertension in Peripheral Arterial Disease. Progress in Cardiovascular Diseases 50:4, 238-263
CrossRef135
Joji Ishikawa, Satoshi Hoshide, Seiichi Shibasaki, Yoshio Matsui, Tomoyuki Kabutoya, Kazuo Eguchi, Shizukiyo Ishikawa, Thomas G. Pickering, Kazuyuki Shimada, Kazuomi Kario. (2008) Relationship Between Morning Hypertension Identified by Home Blood Pressure Monitoring and Brain Natriuretic Peptide and Estimated Glomerular Filtration Rate: The Japan Morning Surge 1 (JMS-1) Study. The Journal of Clinical Hypertension 10:1, 34-42
CrossRef136
(2008) Guías de práctica clínica sobre prevención de la enfermedad cardiovascular: versión resumida. Revista Española de Cardiología 61:1, 82.e1-82.e49
CrossRef137
Rajiv Agarwal, Martin J. Andersen, Robert P. Light. (2008) Location Not Quantity of Blood Pressure Measurements Predicts Mortality in Hemodialysis Patients. American Journal of Nephrology 28:2, 210-217
CrossRef138
Dimitris P. Papadopoulos, Thomas K. Makris. (2007) Masked Hypertension Definition, Impact, Outcomes: A Critical Review. The Journal of Clinical Hypertension 9:12, 956-963
CrossRef139
Gianfranco Parati, Jan A Staessen. (2007) Day–night blood pressure variations: mechanisms, reproducibility and clinical relevance. Journal of Hypertension 25:12, 2377-2380
CrossRef140
Gu-Liang Wang, Yan Li, Jan A Staessen, Lu Lu, Ji-Guang Wang. (2007) Anthropometric and lifestyle factors associated with white-coat, masked and sustained hypertension in a Chinese population. Journal of Hypertension 25:12, 2398-2405
CrossRef141
Anne Sofie Astrup, Flemming S Nielsen, Peter Rossing, Samir Ali, Jens Kastrup, Ulla Meng Smidt, Hans-Henrik Parving. (2007) Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study. Journal of Hypertension 25:12, 2479-2485
CrossRef142
Ihab Hajjar, Magdy Selim, Peter Novak, Vera Novak. (2007) The Relationship Between Nighttime Dipping in Blood Pressure and Cerebral Hemodynamics in Nonstroke Patients. The Journal of Clinical Hypertension 9:12, 929-936
CrossRef143
Mahboob Rahman, Lawrence J. Appel. (2007) Should Reducing Nocturnal Blood Pressure Be a Therapeutic Target in CKD? The Time Is Ripe for a Clinical Outcomes Trial. American Journal of Kidney Diseases 50:6, 901-903
CrossRef144
Manish D Sinha, Christopher JD Reid. (2007) Evaluation of blood pressure in children. Current Opinion in Nephrology and Hypertension 16:6, 577-584
CrossRef145
Robert H Fagard, Véronique A Cornelissen. (2007) Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. Journal of Hypertension 25:11, 2193-2198
CrossRef146
José Boggia, Yan Li, Lutgarde Thijs, Tine W Hansen, Masahiro Kikuya, Kristina Björklund-Bodegård, Tom Richart, Takayoshi Ohkubo, Tatiana Kuznetsova, Christian Torp-Pedersen, Lars Lind, Hans Ibsen, Yutaka Imai, Jiguang Wang, Edgardo Sandoya, Eoin O'Brien, Jan A Staessen. (2007) Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. The Lancet 370:9594, 1219-1229
CrossRef147
Stéphane Laurent. (2007) Day or night blood pressures to predict cardiovascular events?. The Lancet 370:9594, 1192-1193
CrossRef148
Eduardo Pimenta, Krishna K Gaddam, Monique N Pratt-Ubunama, Mari K Nishizaka, Stacey S Cofield, Suzanne Oparil, David A Calhoun. (2007) Aldosterone excess and resistance to 24-h blood pressure control. Journal of Hypertension 25:10, 2131-2137
CrossRef149
Jaekyu Shin, Sharoen Kline, Mariellen Moore, Yan Gong, Viralkumar Bhanderi, Carsten M. Schmalfuss, Julie A. Johnson, Richard S. Schofield. (2007) Association of Diurnal Blood Pressure Pattern With Risk of Hospitalization or Death in Men With Heart Failure. Journal of Cardiac Failure 13:8, 656-662
CrossRef150
Lillian C. Min, Rajnish Mehrotra, Constance H. Fung. (2007) Quality Indicators for the Care of Hypertension in Vulnerable Elders. Journal of the American Geriatrics Society 55, S359-S365
CrossRef151
&NA;. (2007) FULL TEXT Chapter 1: Introduction. European Journal of Cardiovascular Prevention & Rehabilitation 14:Supplement 2, S2-S113
CrossRef152
A Chiolero, P Bovet. (2007) Self blood pressure measurement: a promising procedure but some issues remain unanswered. Journal of Human Hypertension 21:9, 697-698
CrossRef153
Michel Burnier, Lionel Coltamai, Marc Maillard, Murielle Bochud. (2007) Renal Sodium Handling and Nighttime Blood Pressure. Seminars in Nephrology 27:5, 565-571
CrossRef154
(2007) Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007. Revista Española de Cardiología 60:9, 968.e1-968.e94
CrossRef155
Olebogeng HI Majane, Gavin R Norton, Muzi J Maseko, Siyanda Makaula, Nigel Crowther, Janice Paiker, Lutgarde Thijs, Richard Brooksbank, Pinhas Sareli, Jan A Staessen, Angela J Woodiwiss. (2007) The association of waist circumference with ambulatory blood pressure is independent of alternative adiposity indices. Journal of Hypertension 25:9, 1798-1806
CrossRef156
Ian Graham. (2007) European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Atherosclerosis 194:1, 1-45
CrossRef157
William B. White. (2007) Clinical Assessment of Early Morning Blood Pressure in Patients With Hypertension. Preventive Cardiology 10:4, 210-214
CrossRef158
Ramón C. Hermida, Diana E. Ayala, Francesco Portaluppi. (2007) Circadian variation of blood pressure: The basis for the chronotherapy of hypertension. Advanced Drug Delivery Reviews 59:9-10, 904-922
CrossRef159
John S Floras. (2007) Ambulatory blood pressure: facilitating individualized assessment of cardiovascular risk. Journal of Hypertension 25:8, 1565-1568
CrossRef160
Tine W Hansen, Masahiro Kikuya, Lutgarde Thijs, Kristina Bj??rklund-Bodeg??rd, Tatiana Kuznetsova, Takayoshi Ohkubo, Tom Richart, Christian Torp-Pedersen, Lars Lind, J??rgen Jeppesen, Hans Ibsen, Yutaka Imai, Jan A Staessen. (2007) Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals. Journal of Hypertension 25:8, 1554-1564
CrossRef161
Gianfranco Parati, Mariaconsuelo Valentini. (2007) Do we need out-of-office blood pressure in every patient?. Current Opinion in Cardiology 22:4, 321-328
CrossRef162
Walter Palmas. (2007) Ambulatory blood pressure monitoring in patients with diabetes mellitus: Current evidence and future trends. Current Cardiovascular Risk Reports 1:3, 209-215
CrossRef163
Cristina Sierra, Alejandro de la Sierra, Javier Sobrino, Julián Segura, José Ramón Banegas, Manuel Gorostidi, Luis Miguel Ruilope. (2007) Monitorización ambulatoria de la presión arterial (MAPA): características clínicas de 31.530 pacientes. Medicina Clínica 129:1, 1-5
CrossRef164
Manuel Gorostidi, Javier Sobrino, Julián Segura, Cristina Sierra, Álex de la Sierra, Raquel Hernández del Rey, Ernest Vinyoles, Josep M Galcerán, María D López-Eady, Rafael Marín, José R Banegas, Antonio Sarría, Antonio Coca, Luis M Ruilope. (2007) Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20 000-patient database in Spain. Journal of Hypertension 25:5, 977-984
CrossRef165
Gianfranco Parati, Hans Ibsen. (2007) Twenty-four-hour ambulatory blood pressure profiles of high-risk patients in general practice: data from an ambulatory blood pressure monitoring registry. Journal of Hypertension 25:5, 929-933
CrossRef166
Giuseppe Mancia, Gianfranco Parati, Grzegorz Bilo, Alberto Maronati, Stefano Omboni, Hansjörg Baurecht, Michael Hennig, Alberto Zanchetti. (2007) Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis. Journal of Hypertension 25:5, 1087-1094
CrossRef167
Ramón C Hermida, Diana E Ayala, Michael H Smolensky, Francesco Portaluppi. (2007) Chronotherapy in hypertensive patients: administration–time dependent effects of treatment on blood pressure regulation. Expert Review of Cardiovascular Therapy 5:3, 463-475
CrossRef168
Yves Lacourcière, Luc Poirier, Jean Lefebvre. (2007) Expedited blood pressure control with initial angiotensin II antagonist/diuretic therapy compared with stepped-care therapy in patients with ambulatory systolic hypertension. Canadian Journal of Cardiology 23:5, 377-382
CrossRef169
Karen L McNiece, Ronald J Portman. (2007) Ambulatory blood pressure monitoring: what a pediatrician should know. Current Opinion in Pediatrics 19:2, 178-182
CrossRef170
William J. Elliott. (2007) Systemic Hypertension. Current Problems in Cardiology 32:4, 201-259
CrossRef171
K T Larkin, S L Schauss, D M Elnicki, J L Goodie. (2007) Detecting white coat and reverse white coat effects in clinic settings using measures of blood pressure habituation in the clinic and patient self-monitoring of blood pressure. Journal of Human Hypertension
CrossRef172
Jan A Staessen, Tine Willum Hansen, Willem H Birkenhäger. (2007) Added VALUE of an ancillary study on ambulatory blood pressure monitoring. Journal of Hypertension 25:3, 513-515
CrossRef173
Ramón C. Hermida, Diana E. Ayala, José R. Fernández, Artemio Mojón, Carlos Calvo. (2007) Influencia de la duración y la frecuencia de muestreo en la medición ambulatoria de la presión arterial. Revista Española de Cardiología 60:2, 131-138
CrossRef174
Rene’ G. VanDe Voorde, Mark M. Mitsnefes. (2007) Ambulatory blood pressure monitoring - A quest for truth. Pediatric Transplantation 11:1, 10-13
CrossRef175
Cesare Cuspidi, Gianfranco Parati. (2007) Masked hypertension: an independent predictor of organ damage. Journal of Hypertension 25:2, 275-279
CrossRef176
Kazuomi Kario. (2007) Nihon Naika Gakkai Zasshi 96:1, 79-85
CrossRef177
Ramón C. Hermida, Diana E. Ayala, José R. Fernández, Artemio Mojón, Carlos Calvo. (2007) Influence of Measurement Duration and Frequency on Ambulatory Blood Pressure Monitoring. Revista Española de Cardiología (English Edition) 60:2, 131-138
CrossRef178
William B. White. (2007) Ambulatory Blood Pressure Monitoring as an Investigative Tool for Characterizing Resistant Hypertension and Its Rational Treatment. The Journal of Clinical Hypertension 9, 25-30
CrossRef179
W.J. Elliott. (2007) Diurnal Blood Pressure Pattern and Risk of Congestive Heart Failure. Yearbook of Cardiology 2007, 42-44
CrossRef180
W.J. Elliott. (2007) Ambulatory Blood Pressure Monitoring and Risk of Cardiovascular Disease: A Population Based Study. Yearbook of Cardiology 2007, 44-46
CrossRef181
Eui-Seock Hwang, Kee-Joon Choi, Duk-Hyun Kang, Gi-Byoung Nam, Jae-Sik Jang, Young-Hoon Jeong, Chang-Hoon Lee, Ji-Young Lee, Hyun-Koo Park, Chong-Hun Park. (2007) Prevalence, Predictive Factor, and Clinical Significance of White-Coat Hypertension and Masked Hypertension in Korean Hypertensive patients. The Korean Journal of Internal Medicine 22:4, 256
CrossRef182
Guido Grassi, Michele Bombelli, Roberto Sega, Fosca Quarti Trevano, Giovanni Corrao, Fabiana Madotto, Rita Facchetti, Miriam Fiore Panzeri, Giuseppe Mancia. (2007) The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) Study. High Blood Pressure & Cardiovascular Prevention 14:2, 83-88
CrossRef183
M Tomiyama, T Horio, K Kamide, S Nakamura, F Yoshihara, H Nakata, H Nakahama, Y Kawano. (2006) Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension. Journal of Human Hypertension
CrossRef184
Francisco Blanco, Paloma Gil, Carmen del Arco, Teresa S??ez, R??o Aguilar, Isabel Lara, Juan J. de la Cruz, Rafael Gabriel, Carmen Su??rez. (2006) Association of clinic and ambulatory blood pressure with vascular damage in the elderly: the EPICARDIAN study. Blood Pressure Monitoring 11:6, 329-335
CrossRef185
Denis L Clement. (2006) European Society of Hypertension Scientific Newsletter: Control of hypertension in patients with peripheral artery disease. Journal of Hypertension 24:12, 2477-2478
CrossRef186
Anne-Isabelle Tropeano, Fran??oise Roudot-Thoraval, Thierry Badoual, Fran??oise Goldenberg, Guillaume Dolbeau, Philippe Gosse, Isabelle Macquin-Mavier. (2006) Different effects of ambulatory blood pressure monitoring on subjective and objective sleep quality. Blood Pressure Monitoring 11:6, 315-320
CrossRef187
Sante D. Pierdomenico, Domenico Lapenna, Roberta Di Tommaso, Silvio Di Carlo, Anna L. Esposito, Rocco Di Mascio, Enzo Ballone, Franco Cuccurullo, Andrea Mezzetti. (2006) Cardiovascular risk in patients receiving double therapy with false and true nonresponder hypertension. Blood Pressure Monitoring 11:6, 303-307
CrossRef188
John W. Graves, Mohammed Mahdi Althaf. (2006) Utility of ambulatory blood pressure monitoring in children and adolescents. Pediatric Nephrology 21:11, 1640-1652
CrossRef189
Daniel A Duprez, Daniel J Wilson. 2006. Arterial Hypertension. , 19-62.
CrossRef190
A M Thompson, T G Pickering. (2006) The role of ambulatory blood pressure monitoring in chronic and end-stage renal disease. Kidney International 70:6, 1000-1007
CrossRef191
Amber L Beitelshees, Issam Zineh, Hossein N Yarandi, Daniel F Pauly, Julie A Johnson. (2006) Discordant β-Blocker Effects on Clinic, Ambulatory, Resting, and Exercise Hemodynamics in Patients with Hypertension. Pharmacotherapy 26:9, 1247-1254
CrossRef192
Johannes FE Mann, Karl F Hilgers. (2006) Clinic versus home blood-pressure measurements as a predictor of outcomes in chronic kidney disease. Nature Clinical Practice Nephrology 2:9, 474-475
CrossRef193
Grzegorz Bilo, Gianfranco Parati. (2006) Temporal blood pressure patterns and cardiovascular events: ‘good night’ or ‘good morning’?. Journal of Hypertension 24:9, 1703-1705
CrossRef194
Philippe Gosse. (2006) A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours. Vascular Health and Risk Management 2:3, 195-201
CrossRef195
Willem J Verberk, Abraham A Kroon, Alfons GH Kessels, Jacques WM Lenders, Theo Thien, Gert A van Montfrans, Andries J Smit, Peter W de Leeuw. (2006) The optimal scheme of self blood pressure measurement as determined from ambulatory blood pressure recordings. Journal of Hypertension 24:8, 1541-1548
CrossRef196
Mar??a A. Mart??nez, Teresa Sancho, Pilar Garc??a, Pilar Moreno, Jos?? M. Rubio, Francisco J. Palau, Jos?? L. Ant??n, Francisco J. Cirujano, Jos?? Sanz, Juan G. Puig. (2006) Home blood pressure in poorly controlled hypertension: relationship with ambulatory blood pressure and organ damage. Blood Pressure Monitoring 11:4, 207-213
CrossRef197
Giuseppe Mancia, Gianfranco Parati. (2006) Guiding antihypertensive treatment decisions using ambulatory blood pressure monitoring. Current Hypertension Reports 8:4, 330-337
CrossRef198
Christoph D Gatzka. (2006) Activity, environment and blood pressure. Journal of Hypertension 24:7, 1239-1241
CrossRef199
Pickering, Thomas G., Shimbo, Daichi, Haas, Donald, . (2006) Ambulatory Blood-Pressure Monitoring. New England Journal of Medicine 354:22, 2368-2374
Full Text200
R C-C Wong, T C Yeo. (2006) ‘Office-hour’ ambulatory blood pressure monitoring is sufficient for blood pressure diagnosis. Journal of Human Hypertension 20:6, 440-443
CrossRef201
S Ragot, P Sosner, C Yau, P Brunel, D Herpin. (2006) Management in general practice of hypertensive patients poorly controlled with a fixed-dose renin–angiotensin system inhibitor and diuretic combination: results from a French national survey. Journal of Human Hypertension 20:6, 407-418
CrossRef202
Aud-E. Stenehjem, Helga Gudmundsdottir, Ingrid Os. (2006) Office blood pressure measurements overestimate blood pressure control in renal transplant patients. Blood Pressure Monitoring 11:3, 125-133
CrossRef203
Martin G. Dawes, Andrew J. Coats, Edmund Juszczak. (2006) Daytime ambulatory systolic blood pressure is more effective at predicting mortality than clinic blood pressure. Blood Pressure Monitoring 11:3, 111-118
CrossRef204
Rajiv Agarwal. (2006) Hypertension diagnosis and prognosis in chronic kidney disease with out-of-office blood pressure monitoring. Current Opinion in Nephrology and Hypertension 15:3, 309-313
CrossRef205
Edoardo Mannucci, Lorella Lambertucci, Matteo Monami, Angela Fedeli, Veronica Chiasserini, Niccolò Marchionni, Giulio Masotti, Andrea Ungar. (2006) Pulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort study. Diabetes/Metabolism Research and Reviews 22:3, 172-175
CrossRef206
Thomas D Giles. (2006) Circadian rhythm of blood pressure and the relation to cardiovascular events. Journal of Hypertension 24:Suppl 2, S11-S16
CrossRef207
John W. Graves, Brandon R. Grossardt, Rachel E. Gullerud, Kent R. Bailey, Jeffrey Feldstein. (2006) The trained observer better predicts daytime ABPM diastolic blood pressure in hypertensive patients than does an automated (Omron) device. Blood Pressure Monitoring 11:2, 53-58
CrossRef208
R Agarwal, M J Andersen. (2006) Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney International 69:7, 1175-1180
CrossRef209
Àngela Felip-Benach, Javier Sobrino-Martínez. (2006) Cronoterapia en hipertensión arterial. Medicina Clínica 126:10, 18-19
CrossRef210
Brandy K. Frost, Ihab M. Hajjar. (2006) Improving patient outcomes with ambulatory blood pressure monitoring in elderly with hypertension. Journal of the American Academy of Nurse Practitioners 18:3, 104-115
CrossRef211
Gianfranco Parati, Bernard Waeber. (2006) Twenty-four hour blood pressure monitoring: in ambulatory conditions or in-hospital?. Journal of Hypertension 24:2, 265-267
CrossRef212
Sonya S. Brady, Karen A. Matthews. (2006) Chronic stress influences ambulatory blood pressure in adolescents. Annals of Behavioral Medicine 31:1, 80-88
CrossRef213
Bruce F. Culleton, Donald W. McKay, Norman R. Campbell. (2006) Performance of the automated BpTRU??? measurement device in the assessment of white-coat hypertension and white-coat effect. Blood Pressure Monitoring 11:1, 37-42
CrossRef214
David Conen, Benedict Martina, Andre P Perruchoud, Bernd M Leimenstoll. (2006) High prevalence of newly detected hypertension in hospitalized patients: the value of inhospital 24-h blood pressure measurement. Journal of Hypertension 24:2, 301-306
CrossRef215
María Ángeles Martínez-López, Juan García-Puig. (2006) Medición de la presión arterial en el domicilio. Medicina Clínica 126:3, 105-109
CrossRef216
W.J. Elliott. (2006) Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1. Blood Pressure Measurement in Humans. A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Yearbook of Cardiology 2006, 3-4
CrossRef217
Iwao Kuwajima. (2006) Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 43:6, 706-709
CrossRef218
A. Roguin. (2006) Scipione Riva-Rocci and the men behind the mercury sphygmomanometer. International Journal of Clinical Practice 60:1, 73-79
CrossRef219
Hans R Brunner, Kikuo Arakawa. (2006) Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil in Achieving 24-Hour Blood Pressure Reductions and Ambulatory Blood Pressure Goals. Clinical Drug Investigation 26:4, 185-193
CrossRef220
Joji ISHIKAWA, Kazuomi KARIO, Kazuo EGUCHI, Masato MORINARI, Satoshi HOSHIDE, Shizukiyo ISHIKAWA, Kazuyuki SHIMADA. (2006) Regular Alcohol Drinking Is a Determinant of Masked Morning Hypertension Detected by Home Blood Pressure Monitoring in Medicated Hypertensive Patients with Well-Controlled Clinic Blood Pressure: The Jichi Morning Hypertension Research (J-MORE) Study. Hypertension Research 29:9, 679-686
CrossRef221
Hideyuki UNO, Kazuomi KARIO. (2006) Focus on Masked Workplace Hypertension: The Next Step for Perfect 24-Hour Blood Pressure Control. Hypertension Research 29:12, 937-940
CrossRef222
Kazumasa HARADA, Yuya KARUBE, Hirokazu SARUHARA, Kazuhiro TAKEDA, Iwao KUWAJIMA. (2006) Workplace Hypertension Is Associated with Obesity and Family History of Hypertension. Hypertension Research 29:12, 969-976
CrossRef223
Lorenz Sellin, Johannes Stegbauer, Petra Laeis, Lars C Rump. (2005) Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension. Journal of Hypertension 23:11, 2083-2092
CrossRef224
R H Fagard, C Van Den Broeke, P De Cort. (2005) Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. Journal of Human Hypertension 19:10, 801-807
CrossRef225
Timm H. Westhoff, Henriette Straub-Hohenbleicher, Sven Schmidt, Markus T??lle, Walter Zidek, Markus van der Giet. (2005) Convenience of ambulatory blood pressure monitoring: comparison of different devices. Blood Pressure Monitoring 10:5, 239-242
CrossRef226
Demosthenes G. Katritsis, Ioannis K. Toumpoulis, Eleftherios Giazitzoglou, Socrates Korovesis, Ilias Karabinos, George Paxinos, Constantinos Zambartas, Constantine E. Anagnostopoulos. (2005) Latent Arterial Hypertension in Apparently Lone Atrial Fibrillation. Journal of Interventional Cardiac Electrophysiology 13:3, 203-207
CrossRef227
Franz H. Messerli, Delia Cotiga. (2005) Masked Hypertension and White-Coat Hypertension. Journal of the American College of Cardiology 46:3, 516-517
CrossRef228
Carlos A. Feldstein, Maia Akopian, Antonio O. Olivieri, Agustina Pinto Kramer, Magdalena Nasi, Delia Garrido. (2005) A comparison of body mass index and waist-to-hip ratio as indicators of hypertension risk in an urban Argentine population: A hospital-based study. Nutrition, Metabolism and Cardiovascular Diseases 15:4, 310-315
CrossRef229
Robert A Phillips, Joy M Weinberg. (2005) Hypertension 2005: an evidence-based approach to diagnosis and treatment – an American perspective. Expert Review of Cardiovascular Therapy 3:4, 691-704
CrossRef230
Joel M. Neutel, Keith Rotenberg. (2005) Comparison of a Chronotherapeutically Administered ? Blocker vs. a Traditionally Administered ? Blocker in Patients With Hypertension. The Journal of Clinical Hypertension 7:7, 395-400
CrossRef231
Yan Li, Ji-Guang Wang, Pingjin Gao, Huifeng Guo, Tim Nawrot, Guliang Wang, Yuesheng Qian, Jan A Staessen, Dingliang Zhu. (2005) Are published characteristics of the ambulatory blood pressure generalizable to rural Chinese? The JingNing population study. Blood Pressure Monitoring 10:3, 125-134
CrossRef232
Rafael Marín, Álex de la Sierra, Pedro Armario, Carlos Campo, José R. Banegas, Manuel Gorostidi. (2005) Guía sobre el diagnóstico y tratamiento de la hipertensión arterial en España 2005. Medicina Clínica 125:1, 24-34
CrossRef233
C Cuspidi, S Meani, V Fusi, C Valerio, E Catini, F Magrini, A Zanchetti. (2005) Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. Journal of Human Hypertension 19:6, 471-477
CrossRef234
Martin J. Andersen, Wassim Khawandi, Rajiv Agarwal. (2005) Home Blood Pressure Monitoring in CKD. American Journal of Kidney Diseases 45:6, 994-1001
CrossRef235
Mark A. Brown, George Mangos, Greg Davis, Caroline Homer. (2005) The natural history of white coat hypertension during pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology 112:5, 601-606
CrossRef236
Martin J. Andersen, Rajiv Agarwal. (2005) Etiology and Management of Hypertension in Chronic Kidney Disease. Medical Clinics of North America 89:3, 525-547
CrossRef237
Luis M Ruilope, Daniela Heintz, Andrea A Brand??o, Pelle Stolt, Albert Kandra, Massimo Santonastaso, Yasser Khder. (2005) 24-hour ambulatory blood-pressure effects of valsartan & hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: A VAST sub-study. Blood Pressure Monitoring 10:2, 85-91
CrossRef238
Thomas Giles. (2005) Relevance of blood pressure variation in the circadian onset of cardiovascular events. Journal of Hypertension 23:Suppl 1, S35-S39
CrossRef239
Victor Dzau. (2005) The cardiovascular continuum and renin–angiotensin–aldosterone system blockade. Journal of Hypertension 23:Suppl 1, S9-S17
CrossRef240
Roland W. McCallum, Christopher A. R. Sainsbury, Angela Spiers, Anna F. Dominiczak, John R. Petrie, Naveed Sattar, John M. C. Connell. (2005) Growth hormone replacement reduces C-reactive protein and large-artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency. Clinical Endocrinology 62:4, 473-479
CrossRef241
Thomas G. Pickering. (2005) Should We Be Evaluating Blood Pressure Dipping Status in Clinical Practice?. The Journal of Clinical Hypertension 7:3, 178-182
CrossRef242
Thomas G. Pickering, John E. Hall, Lawrence J. Appel, Bonita E. Falkner, John W. Graves, Martha N. Hill, Daniel W. Jones, Theodore Kurtz, Sheldon G. Sheps, Edward J. Roccella. (2005) Recommendations for Blood Pressure Measurement in Humans: An AHA Scientific Statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. The Journal of Clinical Hypertension 7:2, 102-109
CrossRef243
Terry Young, Shahrokh Javaheri. 2005. Systemic and Pulmonary Hypertension in Obstructive Sleep Apnea. , 1192-1202.
CrossRef244
Christopher Hassler, Michel Burnier. (2005) Circadian Variations in Blood Pressure. American Journal of Cardiovascular Drugs 5:1, 7-15
CrossRef245
Joel M. NEUTEL, Thomas W. LITTLEJOHN, Steven G. CHRYSANT, Ashish SINGH. (2005) Telmisartan/Hydrochlorothiazide in Comparison with Losartan/Hydrochlorothiazide in Managing Patients with Mild-to-Moderate Hypertension. Hypertension Research 28:7, 555-563
CrossRef246
Barbara Casadei, Hala Abuzeid. (2005) Is there a strong rationale for deferring elective surgery in patients with poorly controlled hypertension?. Journal of Hypertension 23:1, 19-22
CrossRef247
Yasumasa YAMAMOTO, Kaiyo OIWA, Masamichi HAYASHI, Tomoyuki OHARA, Manabu MURANISHI. (2005) Effect of the Angiotensin-Converting Enzyme Inhibitor Perindopril on 24-Hour Blood Pressure in Patients with Lacunar Infarction: Comparison between Dippers and Non-Dippers. Hypertension Research 28:7, 571-578
CrossRef248
C. Richards, M. Sutherland, K. Gough, P.L. Padfield. (2004) Direct access ambulatory BP monitoring???the Edinburgh experience. Blood Pressure Monitoring 9:6, 287-291
CrossRef249
Martin G. Myers. (2004) Blood pressure measurement and the guidelines: a proposed new algorithm for the diagnosis of hypertension. Blood Pressure Monitoring 9:6, 283-286
CrossRef250
Robert A. Phillips. (2004) Ambulatory Blood Pressure Monitoring for Every Hypertensive Patient: It's About Time!. The Journal of Clinical Hypertension 6:12, 708-710
CrossRef251
Cora Mc Greevy, Jane Mulrooney, Sean T. O'Keeffe, Eamon C. Mulkerrin. (2004) Do Older People Tolerate Ambulatory Blood Pressure Monitoring?. Journal of the American Geriatrics Society 52:10, 1780-1781
CrossRef252
Marianne Soergel. (2004) Is ABPM clinically useful after pediatric solid organ transplantation?. Pediatric Transplantation 8:5, 433-436
CrossRef253
Mónica E. Del Compare, Daniel D'Agostino, Jorge R. Ferraris, Gustavo Boldrini, Gabriel Waisman, Rafael T. Krmar. (2004) Twenty-four-hour ambulatory blood pressure profiles in liver transplant recipients. Pediatric Transplantation 8:5, 496-501
CrossRef254
Eoin O??Brien, Neil Atkins. (2004) Can improved software facilitate the wider use of ambulatory blood pressure measurement in clinical practice?. Blood Pressure Monitoring 9:5, 237-241
CrossRef255
Evelyn Mentari, Mahboob Rahman. (2004) Blood pressure and progression of chronic kidney disease: Importance of systolic, diastolic, or diurnal variation. Current Hypertension Reports 6:5, 400-404
CrossRef256
Robert H Fagard, Hilde Celis. (2004) Prognostic significance of various characteristics of out-of-the-office blood pressure. Journal of Hypertension 22:9, 1663-1666
CrossRef257
Adrian Covic, Ali A. Haydar, David Goldsmith. (2004) HYPERTENSION IN HEMODIALYSIS PATIENTS: Ambulatory Blood Pressure Monitoring in Hemodialysis Patients: A Critique and Literature Review. Seminars in Dialysis 17:4, 255-259
CrossRef258
Marinel Cavelaars, Joke HM Tulen, Jan H van Bemmel, Paul GH Mulder, Anton H van den Meiracker. (2004) Reproducibility of intra-arterial ambulatory blood pressure. Journal of Hypertension 22:6, 1105-1112
CrossRef259
Gianfranco Parati, Grzegorz Bilo, Giuseppe Mancia. (2004) Blood pressure measurement in research and in clinical practice: recent evidence. Current Opinion in Nephrology and Hypertension 13:3, 343-357
CrossRef260
(2004) References. American Journal of Kidney Diseases 43, 268-290
CrossRef261
Rita D Swinford, Ronald J Portman. (2004) Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease. Advances in Chronic Kidney Disease 11:2, 143-161
CrossRef262
Ayumu ONO, Toshiro FUJITA. (2004) Predictors of Controlled Ambulatory Blood Pressure in Treated Hypertensive Patients with Uncontrolled Office Blood Pressure. Hypertension Research 27:11, 805-811
CrossRef263
Cynthia Cheng, James S. Studdiford, James J. Diamond, Christopher V. Chambers. (2003) Primary care physician beliefs regarding usefulness of self-monitoring of blood pressure. Blood Pressure Monitoring 8:6, 249-254
CrossRef264
White, William B., . (2003) Ambulatory Blood-Pressure Monitoring in Clinical Practice. New England Journal of Medicine 348:24, 2377-2378
Full Text265
Ye Tun, Wataru Hida, Shinichi Okabe, Hiromasa Ogawa, Yoshihiro Kikuchi, Manami Oikawa, Tomomi Kitamuro, Kunio Shirato. (2003) Can Nasal Continuous Positive Airway Pressure Decrease Clinic Blood Pressure in Patients with Obstructive Sleep Apnea?. The Tohoku Journal of Experimental Medicine 201:3, 181-190
CrossRef
